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Abstract 
 In Canada, the number of older adults has been on the rise over the past several decades. 
As the aging population continues to rise, the prevalence of chronic illnesses is projected to 
correspondingly increase at an unprecedented rate. Another factor contributing to the rise of 
chronic diseases is the significant disparities in disease burden that exist among certain ethnic 
minority groups in Canada’s multicultural society. South Asians (SA) constitute the largest 
minority group in Canada and suffer from a disproportionately high burden of heart disease and 
stroke compared to the rest of the population. Arterial stiffness is a hallmark characteristic of 
vascular aging and a recognized process that is linked to the development of cardio- and 
cerebrovascular diseases. A recent study conducted in our laboratory on healthy Caucasian (CA) 
older adults has found that elevated arterial stiffness is associated with increased cerebrovascular 
resistance, and this is in turn associated with reduction in brain blood flow (aCBF). This finding 
presents the possibility that SAs, who are reported to have elevated levels of arterial stiffness 
compared to their CA counterparts, may exhibit greater cerebrovascular resistance and greater 
reduction in aCBF, and as a consequence they may be more prone to cerebral hypoperfusion and 
subsequent ischemia. The primary purpose of this thesis was to examine differences in central 
arterial structure and function and cerebrovascular hemodynamic properties in CA and SA older 
adults matched for age and gender, and to explore ethnic differences in the relationship between 
arterial stiffness and aCBF. The secondary objective was to compare physical activity as well as 
cognitive performance between CAs and SAs and explore their relationship with characteristics of 
central arterial and cerebrovascular health. This study found that older adults of SA origin have 
greater arterial stiffness compared to older adults of CA origin, and that this was associated with 
greater cerebrovascular resistance and correspondingly greater reduction in aCBF in SAs. In 
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addition, arterial wall thickness, IMT, appeared to be less pronounced in SAs compared to CAs, 
yet IMT was associated with greater resistance and pulsatility of blood flow in the cerebral vessels 
in SAs compared to CAs. SA older adults in this study lived a relatively sedentary lifestyle 
compared to CA older adults; nonetheless, physical activity of daily living among SA older adults 
was associated with lower glycemic levels and lower abdominal obesity (approximated by waist 
circumference and waist-to-hip ratio). With regards to cognitive performance, SAs performed 
slower on reaction time tasks compared to CAs. No significant relationships between cognitive 
performance and central arterial and cerebrovascular health were observed. Taken together, the 
findings from this study suggest ethnic disparities between CAs and SAs in vascular aging 
properties that may contribute to more pronounced alterations in cerebral hemodynamics in SAs. 
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1 Literature Review 
1.1 Vascular Health and Disease with Aging 
1.1.1 Definition of Vascular Aging 
 Vascular aging is a natural process by which the vasculature undergoes progressive 
changes during aging. The major structural changes include the breakdown of elastin and 
deposition of collagen protein fibers, vascular remodeling, vascular smooth muscle cell 
proliferation and hypertrophy, and endothelial dysfunction (Nichols et al., 2011). With advancing 
age, these alterations promote arterial stiffening and vessel wall thickening that substantially affect 
arterial function and regulation of blood flow.  
When the heart contracts and ejects blood into the circulatory system, pressure pulse waves 
are generated and propagate along the arterial tree. The first conduit vessels that receive blood 
from the heart are central elastic arteries that are structurally designed to accommodate the ejected 
blood and functionally designed to distend and recoil to reduce the pulsatility of pressure waves 
generated by each heartbeat.  In this way, the central arteries ensure constant blood flow and protect 
the small distal arteries from the transmission of high pulsatile energy. Normally, as pressure 
waves travel forward from central to peripheral arteries, they reflect back to the center when they 
encounter regions of impedance mismatch, such as branch points, which arise from differences in 
diameter and structural composition of vessels along the arterial tree (Latham et al., 1985). In turn, 
the reflected waves amplify the incoming waves in late systole and early diastole (Nichols et al., 
2011). The resultant pressure waves drive blood flow during both systole and diastole that is 
necessary for adequate delivery of oxygen and nutrients to meet the metabolic demands of 
downstream organs and tissues in the human body.  
2 
 
Wave propagation and reflection vary considerably with age. The mechanical stretching 
and recoil of central arteries with each heartbeat can cause molecular and structural changes that 
accumulate over time with advancing age, which in part, causes the elastin fibers in the arterial 
wall to fatigue and breakdown while stiff collagen fibers begin to predominate (Samila & Carter, 
1981). This natural degenerative process, along with the other aforementioned structural 
alterations, increase arterial stiffness and reduce central arterial compliance. Consequently, these 
changes influence hemodynamic properties, whereby the pressure waves move faster and reflect 
early to return in systole rather than diastole, resulting in amplified systolic and reduced diastolic 
pressure of incoming waves (Figure 1). In this situation, low resistance downstream vascular beds 
near organs that demand high volume of blood flow to meet their energy needs, such as the brain, 
are exposed to these high pulsatile pressure waves that potentially can cause substantial damage 
to the vessels and surrounding tissues. 
 
Figure 1. Schematic Diagram Representing Pressure Waveforms in Compliant (Left) and 
Stiff (Right) Central Arteries. In a healthy, young elastic artery, the forward wave (P1) created 
by the contraction of the heart determines the systolic blood pressure, and a reflected wave 
generated in the periphery (P2) returns towards the heart and amplifies the pressure during diastole. 
As the central arteries begin to age and stiffen, blood travels faster, and the reflected wave (P2) 
returns earlier, thereby increasing systolic blood pressure (ΔP) and pulse pressure (PP). Modified 
from Oliver & Webb (2003). 
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1.1.2 Vascular Aging and Disease  
The physiological changes of the human vasculature with aging contribute to the decline 
in cardiovascular function. Many of the chronic diseases older adults suffer from are to some extent 
related to the long-term consequences of altered hemodynamic blood flow patterns associated with 
vascular aging. For instance, increased central arterial stiffness is associated with organ failure, 
including end-stage renal damage (Safar, 2002), as well as cerebrovascular diseases, such as stroke 
(Laurent et al., 2003). In addition, increased risk of stroke and myocardial infarction is related to 
increased arterial thickness in older adults (O’Leary et al., 1999). Together, these findings suggest 
that individuals with greater vascular changes (i.e. accelerated vascular aging) are at a greater risk 
of developing cardiovascular and cerebrovascular diseases compared with their age-matched 
counterparts. Therefore, it is important to understand differences in the extent of vascular changes 
during aging among individuals because these changes may help stratify risk and identify those 
most vulnerable to cardiovascular events. 
In addition to age, hypercholesterolemia (Wilkinson et al., 2002), hyperglycemia (Aoun & 
Blacher, 2001; Schram et al., 2004), and increased levels of inflammatory markers (Mattace-Raso 
et al., 2004), are associated with increased arterial stiffness. Nevertheless, arterial stiffness can be 
modified by lifestyle habits, such as physical activity. Individuals who are regularly active have 
less central arterial stiffness and largely preserved vascular health with age (Rogers et al., 1990; 
Vaitkevicius et al., 1993; Ainslie et al., 2008; Miyazaki et al., 2011). Even light intensity activities 
confer health benefits among older adults (Gando et al., 2010). As such, promoting physical 
activity holds great promise in attenuating the age-related changes of the vasculature, thereby 
delaying the risk of associated diseases. 
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1.1.3 Vascular Age Assessments 
Several non-invasive techniques have emerged to quantify the age-related changes in the 
vasculature. Indicators of arterial stiffness and thickness are commonly measured to provide 
information about arterial structure and function. For instance, arterial stiffness is evaluated by 
pulse wave velocity (PWV) and central pulse pressure analysis. PWV refers to the speed that 
pressure pulse waves travel over a defined distance along an arterial segment, which increases with 
greater arterial stiffness. Central pulse pressure (the difference between systole and diastole) is 
derived from pressure waveforms at the common carotid artery. Normally, the pressure waveform 
changes as it travels from central to peripheral arteries; the systolic peak gradually increases as a 
function of wave reflection (Kroeker & Wood, 1955; Wilkinson et al., 2001). This pressure wave 
amplification phenomenon is not present in older adults because central arteries become stiff, and 
therefore, central pulse pressure is similar to peripheral pulse pressure. For this reason, arterial 
pulse pressure is considered an appropriate marker of arterial stiffness in older adults compared to 
young adults.  
Thickening of the arterial wall is another hallmark characteristic of aging (Howard et al., 
1993). The vessel wall is made of three layers: adventitia, which is the outermost layer composed 
of connective tissues; media, which is the middle layer composed of smooth muscle cells, elastin 
and collagen fibers; and intima, which is a single layer of endothelial cells that line the vessel 
lumen. Thickness is visually assessed using ultrasound, which allows for visualization of the vessel 
wall. The common carotid artery (CCA) on either side of the neck is commonly used for measuring 
intima-medial thickness (IMT). CCA is the major artery that supplies oxygen-rich blood to the 
brain (Sojkova et al., 2010). IMT is defined as the measured distance between the lumen-intimal 
interface and the media-adventitial interface of the far wall. IMT is a major indicator of arterial 
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health and an early detection measurement for atherosclerosis and its progression (Persson et al., 
1994).  
 Together, arterial stiffness and IMT measurements provide a comprehensive evaluation of 
vascular health. They are both considered valuable measurements because they improve risk 
prediction for future cardio- and cerebrovascular diseases and are related to mortality and 
morbidity in older adults, as well as in the general population (Meaume et al., 2001; Mattace-Raso 
et al., 2006; Willum-Hansen et al., 2006; Lorenz et al., 2007). Although cardiovascular risk factors 
(e.g., hypertension, fasting plasma glucose levels, cholesterol, and smoking) can contribute to the 
increased risk of cardio- and cerebrovascular diseases in older adults, evidence suggests that 
arterial stiffness and thickness measurements independently predict future cardiovascular events 
after adjustments are made for these risk factors (Simons et al., 1999; Sutton-Tyrrell et al., 2005; 
Mitchell et al., 2010; Lunder et al., 2012).  
1.1.4 Role of Central Vascular Aging on Cerebral Hemodynamics 
Evidence suggests that faster PWV, an indicator of increased arterial stiffness, is associated 
with the prevalence and severity of cerebral infarctions and white matter hyperintensities 
(Hatanaka et al., 2011; Saji et al., 2011, 2012b; Poels et al., 2012b). Several studies have also 
shown that increased arterial stiffness is associated with cognitive dysfunction (Scuteri et al., 2007; 
Waldstein et al., 2008; Triantafyllidi et al., 2009; Watson et al., 2011). These findings have major 
implications for older adults given that arterial stiffness increases with advancing age. Older adults 
are at high risk of cerebral microvascular damage associated with increased arterial stiffness (Tsao 
et al., 2013). The link between age-related central arterial stiffness and cerebrovascular damage 
might be mediated by highly pulsatile pressure and flow, which are transmitted to the small vessels 
in the brain (Kidwell et al., 2001; Hirata et al., 2006; Mitchell et al., 2011; Xu et al., 2012; Webb 
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et al., 2012a). Therefore, increased arterial stiffness could contribute to the pathogenesis of 
cerebral small vessel disease in older adults.  
 Previous work in our laboratory on older adults without clinically overt cardio- and 
cerebrovascular diseases has shown that increased central arterial stiffness is associated with 
increased cerebrovascular resistance, which corresponds to reduction in CBF (Robertson et al., 
2010). Increased resistance to flow may represent a protective mechanism that limits the 
transmission of high pulsatile pressure and flow in the cerebral microcirculation in an attempt to 
prevent any severe damage to the blood vessels and surrounding brain tissue (Tarumi et al., 2011). 
Chronically low CBF as a consequence of increased cerebrovascular resistance has the potential 
to compromise normal tissue perfusion and increase the risk for ischemic tissue damage if 
metabolic needs of brain tissues are not sufficiently met (Nichols et al., 2011). Normally, resting 
CBF declines with aging (Buijs et al., 1998; Scheel et al., 2000), which indicates that older adults 
have a compromised cerebral perfusion state due to their advanced age. The brain has a high 
metabolic rate and requires continuous CBF for sufficient supply of oxygen and metabolic 
substrates for normal brain function and tissue integrity. Even a slight decrease in resting CBF that 
is not directly mediated by the changes in the brain’s metabolic demands could compromise 
adequate tissue perfusion. These circumstances could trigger ischemic events, such as stroke, due 
to an inadequate supply of oxygen and nutrients to the brain (Powers et al., 1985). This means that 
older adults with chronically elevated arterial stiffness may be at greater risk for cerebral 
hypoperfusion because they likely have diminished CBF that is mediated by increased 
cerebrovascular resistance.  
Although the mechanisms underlying these relationships are not entirely understood, there 
is evidence to suggest that vascular aging of central arteries is associated with altered cerebral 
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hemodynamics and may be involved in the manifestation of cerebrovascular diseases associated 
with aging. 
 
1.2 Ethnic Differences in Vascular Aging  
Vascular changes with aging occur in all populations, although the rate and related 
consequences of these changes are not necessarily the same. Ethnicity can explain some of the 
variation in arterial stiffness not accounted for by aging and traditional cardiovascular risk factors. 
Ethnicity is a non-modifiable risk factor that has been identified as a marker of increased risk for 
cardiovascular and cerebrovascular diseases, such as stroke (Sheth et al., 1999; Anand et al., 2000; 
Chiu et al., 2010).  
1.2.1 Arterial Stiffness in South Asians 
 South Asian (SA) ethnicity refers to individuals originating from the southern region of the 
Asian continent, which includes India, Pakistan and Sri Lanka. In Canada, SAs are currently the 
largest and one of the fastest growing visible minority group. They account for the largest 
proportion of immigrants settled in Canada in recent decades, and this trend is projected to continue 
in the coming years (Statistics Canada, 2009). People of SA ethnicity have been recognized to 
have a higher risk of cardio- and cerebrovascular disease than those of other ethnic groups. In 
particular, SAs have the highest prevalence and incidence of heart disease, stroke, and small vessel 
disease (Gunarathne et al., 2009a; Boparai et al., 2011). Evidence suggests that the increased 
susceptibility to these diseases among SAs could be attributed to the increased degree of arterial 
stiffness. SAs have significantly faster PWV and increased pulse wave reflection compared to age- 
and gender-matched Caucasians (CA), independent of established cardiovascular risk factors (Din 
et al., 2006; Gunarathne et al., 2008b). Furthermore, SA stroke patients are reported to have greater 
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arterial stiffness compared to stroke patients from other ethnic groups (Gunarathne et al., 2009a; 
De Silva et al., 2009). Based on these observations, SAs appear to have adverse changes in vascular 
structure and function compared to CAs at any given age. Age is a significant independent 
predictor of arterial stiffness in both ethnicities, and it seems that SAs have an “accelerated” 
vascular aging process, which could contribute to the early pathology and excess risk of vascular 
diseases. Unfortunately, studies currently direct little attention to hemodynamic changes in the 
cerebral circulation that might be associated increased arterial stiffness in SAs. Given that SAs 
have elevated arterial stiffness, blood flow to the brain could be transmitted at high pressure, 
potentially inducing cerebral vessel remodelling and damage and having adverse effects on 
cerebral hemodynamics. Hence, the differences observed in the severity and associated risk of 
developing cerebrovascular disease between SA and CA ethnic groups could be related to the 
ethnic differences in the degree of arterial stiffness and its impact on the cerebral circulation. 
1.2.2 Altered Cerebral Hemodynamics in South Asians 
Middle-aged SAs are reported to have elevated blood flow velocity, pulsatility, and 
cerebrovascular resistance in the cerebral circulation compared to age- and gender-matched CAs 
(Bathula et al., 2011). These findings support the notion that SAs have altered cerebral 
hemodynamics, which might contribute to increased risk of cerebrovascular damage and 
cerebrovascular disease. Surprisingly, the study did not find a significant difference in arterial 
stiffness between the two ethnic groups, implying that arterial stiffness may not necessarily explain 
the cerebrovascular hemodynamic differences observed between the SA and CA group. The 
researchers found that ethnic differences in cerebral hemodynamics was abolished when glycemic 
status was considered, and therefore, suggest that hyperglycaemia may explain the abnormal 
cerebral hemodynamics observed in SA group (Bathula et al., 2011). However, the study design 
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raises several caveats that need to be addressed when interpreting the results. First, there is a 
significant number of comorbidities (e.g., diabetes, metabolic syndrome, and coronary heart 
disease) in the study population that other studies suggest are independently associated with 
increased arterial stiffness (Salomaa et al., 1995a; Scuteri et al., 2004; Mattace-Raso et al., 2006). 
Such comorbidities are also related to altered cerebrovascular hemodynamics. For instance, 
cerebral blood flow velocity and cerebrovascular resistance are significantly elevated in diabetic 
patients compared to healthy patients, implying that hyperglycemia could be a major factor 
influencing cerebral hemodynamics (Lee et al., 2000). Such comorbidities appear to 
synergistically augment the vascular structural and functional changes with aging, and therefore, 
produce considerable amount of variability in the measures of arterial stiffness among individuals. 
Therefore, the presence of these comorbidities in the study conducted by Bathula and colleagues 
(2011) could have confounded the ethnic differences in arterial stiffness, and hence, non-
significant difference in pulse wave velocity were reported (p=0.10). The SA group in Bathula and 
colleagues’ (2011) study had a greater proportion of diabetics compared to the CA group (28.4% 
and 6.3%, respectively). This disproportionate number of diabetic patients among the ethnic 
groups may have influenced the relationship reported between hyperglycemia and altered 
cerebrovascular hemodynamics in SA group. A more appropriate approach would be to study 
cerebrovascular hemodynamic properties in the absence of diabetic patients to elucidate whether 
the differences between the ethnic groups are in fact due to glycemic status. Therefore, it is 
important to evaluate healthy individuals without comorbidities to minimize such confounding 
factors that limit or mask the true interpretation of the data, especially when understanding the 
mechanisms associated with disease development and risk among populations that display 
differential susceptibility. 
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Although the study conducted by Bathula and colleagues (2011) was not specifically 
designed to assess the role of arterial stiffness in cerebral hemodynamic patterns among SAs and 
CAs, the researchers found a positive correlation between PWV and cerebrovascular resistance 
(r=0.338, p<0.0001), and a negative correlation between PWV and mean cerebral blood flow 
velocity in the middle cerebral artery (r= -0.157, p=0.01) in the total study sample. These results 
suggest that both CAs and SAs in the study sample exhibited a significant relationship between 
age-related changes in central vascular structure and function and cerebrovascular hemodynamic 
properties. Significant findings have emerged from this study, yet there is still a need for direct 
evidence to support the role of central vascular changes in cerebral hemodynamics in SAs. 
In recognition that middle-aged SAs have increased arterial stiffness and exhibit altered 
cerebral hemodynamic properties in comparison to age-matched CAs, there is a need to ascertain 
whether a difference in arterial stiffness between SAs and CAs persist with aging, and if it is linked 
to ethnic differences in cerebral hemodynamics. It is possible that SA older adults experience an 
even greater decline in CBF with aging as a consequence of having both greater arterial stiffening 
and increased cerebrovascular resistance compared to CA older adults. In other words, increased 
arterial stiffness may explain the increased risk of ischemic damage and cerebrovascular disease 
in SAs compared to CAs.  
Taken together, research on SAs is particularly important considering that they are the 
largest growing minority group in Canada and have the highest prevalence of cardio- and 
cerebrovascular disease compared to other ethnic groups. The rising number of SA population 
urgently calls for understanding ethnic differences to implement appropriate effective prevention 
strategies to maximize the likelihood of healthy aging for all individuals in Canada’s multicultural 
society.  
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1.3 Implications of Cerebrovascular Carbon Dioxide Reactivity 
In addition to the observed reduction in resting CBF with aging, the dynamic regulation of 
CBF declines with age (Galvin et al., 2010). Cerebrovascular reactivity to carbon dioxide (CO2) 
is commonly used to assess the capacity to which cerebral microvessels respond to changes in 
arterial blood CO2 by adjusting their radius, thereby changing the resistance to flow. The vessels 
dilate with increased CO2 (hypercapnia) and constrict with decreased CO2 (hypocapnia). 
Cerebrovascular reactivity to CO2 is used to assess endothelial function of small cerebral vessels 
and cerebrovascular integrity. A relatively low cerebral vasomotor reactivity to CO2 reflects 
impaired cerebral capacity to appropriately respond (increase CBF) to vasoactive stimuli, which 
can be detected prior to clinical presentation of cerebrovascular disease, and is associated with 
increased risk of ischemic events in the brain (Bakker et al., 1999; Markus, 2001). This method 
challenges small cerebral vessels to reveal cerebrovascular hemodynamic abnormalities that may 
become more pronounced in a dynamic test than when it is examined at rest. 
 The cerebral vessels regulate CBF through a myogenic response to changes in blood 
pressure. Cerebrovascular tone is also mediated by endothelium-dependent mechanisms 
(Schmetterer et al., 1997; Lavi et al., 2003, 2006; Barnes et al., 2012). The vascular endothelium 
is a monolayer of cells that forms an interface between circulating blood and the medial layer of 
the vessel wall that is comprised of smooth muscle cells. The endothelium releases agents that act 
on the vascular smooth muscles to regulate vascular tone (Sandoo et al., 2010). As such, the 
maintenance of endothelium integrity and function is critical for the preservation of cardiovascular 
health.  
Endothelium-derived nitric oxide (NO) is a major mediator of vasodilation, and decreased NO 
production and bioavailability is characteristic of endothelial dysfunction of peripheral vessels 
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(Vallance et al., 1989). Endothelial function progressively declines with age and is considered an 
early pathological condition that is linked to the increased risk of cardiovascular disease 
(Celermajer et al., 1992; Gerhard et al., 1996). Several studies support the involvement of 
endothelium derived-NO in mediating the cerebral vessel response to CO2 (Lavi et al., 2003, 2006; 
Ainslie et al., 2007); however, the precise role of NO in cerebral vasodilation in not entirely clear. 
Cerebrovascular reactivity is impaired in patients with peripheral endothelial dysfunction (Lavi et 
al., 2006), suggesting a potential link between peripheral and cerebral vasomotor activity. These 
findings are particularly important because SAs are reported to have impaired peripheral 
endothelial function compared to age-matched CAs (Murphy et al., 2007), yet little is known 
regarding the dilatory capacity of cerebral vessels among SAs. Adverse cerebrovascular 
hemodynamics are reported in SAs (Bathula et al., 2011), which may be a consequence of 
morphological changes or impaired endothelial function of cerebral vessels. Therefore, this thesis 
examined cerebrovascular reactivity to CO2 in SAs for a more comprehensive assessment of 
cerebrovascular function and the regulation of CBF. This assessment could shed light on potential 
mechanisms to better understand ethnic differences in cerebrovascular disease risk. 
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2 Objectives  
Primary Objective: 
1) Compare structural and functional vascular health and cerebral hemodynamics between 
CA and SA older adults matched for age and gender. 
2) Ascertain whether arterial stiffness is associated with resting cerebral blood flow (aCBF) 
and whether this relationship differs between CAs and SAs.  
Secondary Objective: 
1) Explore relationships between the structural and functional vascular properties and 
cerebral hemodynamics in CA and SA older adults. 
2) Examine differences in blood biomarkers and physical activity between CAs and SAs. 
3) Examine differences in cognitive performance between CAs and SAs and explore the 
relationship between central arterial and cerebrovascular health and cognitive 
performance. 
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3 Hypotheses 
1. SA group will exhibit greater central arterial stiffness compared to CA group.  
2. Baseline aCBF will be lower in SAs relative to CAs. 
3. Cerebrovascular reactivity during hypercapnia will be lower in SAs relative to CAs. 
4. Baseline aCBF will be negatively correlated with indices of central arterial stiffness and 
that this relationship will be stronger in SAs compared to CAs. 
5. Fasting levels of metabolic markers will be higher in SAs compared to CAs. 
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4 Methods 
Experimental procedures and data collection techniques were consistent in both ethnic 
groups to ensure accurate comparability of data. Some modifications, additional methods, as well 
as methodological and analytical considerations, are highlighted in this section. All experimental 
procedures and measurements have been reviewed and approved by the Office of Research Ethics 
at the University of Waterloo (ORE#19197). 
 
4.1 Study Population  
i) SA participants  
Twenty-two community-dwelling older adults of SA origin (11 males, 11 females) 
participated in the study. SAs determined by self-report, were defined as individuals with both 
parents born in the Indian subcontinent (e.g., India, Pakistan, Bangladesh). Participants were 
recruited from a senior community center, various religious temples, and the public community at 
large in the Waterloo and Peel Regions of Ontario. Participants volunteered freely after receiving 
information about the study from public presentations, radio advertisements, as well as through 
word of mouth. Interested participants were phone interviewed to review their medical history in 
light of the inclusion and exclusion criteria for this study (Appendix A). Eligible participants were 
scheduled for testing and given specific instructions to standardize the methods and minimize 
possible physiological variability on the day of testing, which included refraining from alcohol 
consumption (Riff et al., 1969; Kupari et al., 2009); caffeine (Whitsett et al., 1984; Lunt et al., 
2004); and nicotine for 24 hours (Benowitz et al., 1984); as well as to avoid exercise for at least 
12 hours prior to testing day. Every participant was also told to fast overnight for at least 8 hours 
prior to arrival in order to obtain early-morning venous blood samples. 
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ii) CA participants 
 Twenty-two SAs were age- and gender-matched to CA participants whose data had been 
previously collected from this lab and can be found in Dr. A.D. Robertson’s thesis dissertation 
(Robertson, 2013). Whereas data from each CA participant were collected over a span of two days, 
data collection from each SA participant in the current study was condensed into a single day for 
logistic reasons. 
 
4.2 Overview of Experimental Design  
The study was conducted at the University of Waterloo Vascular Aging and Brain Health 
Laboratory. The study protocol was divided into two sections: morning and afternoon. In brief, 
participants arrived in the morning and signed the informed consent; then, fasting blood samples 
were drawn, and height and weight were measured. Once the measurements were complete, a 
health status questionnaire was administered face to face, followed by an assessment of cognitive 
performance. The experimental testing took place early afternoon for all participants, similar to 
when testing had been previously conducted on CA group, to minimize the variability in the cardio- 
and cerebrovascular measures associated with the time of day (Diamant et al., 2002; Ainslie et al., 
2007). Testing procedures included measurements of arterial structure and function, resting 
baseline aCBF, and cerebrovascular reactivity to CO2. At the end of the test, participants were 
given a wireless activity monitor to take home and wear for 3 consecutive days to provide an 
estimate of their current physical activity patterns. They were instructed to wear the armband on 
the right upper arm over the triceps muscle for 3 whole days, while continuing with their normal 
daily routines and activities, and to remove it only when showering or swimming. Once complete, 
each participant returned the monitor in person.  
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4.3 Part One: Morning Session 
4.3.1 Biochemical and Basic Anthropometric Measurements 
After the written consent was obtained, approximately 25 mL fasting blood sample was 
drawn from each participant by a trained and certified technician who performed a venipuncture 
of an antecubital vein in the forearm according to standard procedures. The blood sample was 
analyzed for fasting glucose, glycosylated hemoglobin (HbAlc), hematocrit, triglycerides, 
cholesterol, and C-reactive protein (CRP). Insulin and glycated albumin were two additional blood 
markers analyzed in only SA group based on literature suggesting the involvement of insulin 
resistance and abnormal glycemic control in cardiovascular disease risk (McKeigue et al., 1991; 
Selvin et al., 2011; Moon et al., 2012; Song et al., 2012; Mebazaa et al., 2013). Glycated albumin 
has gained considerable clinical interest as a short-term measure of glycemic changes and has been 
proposed as a more accurate and useful measure of glycemic status than HbA1c (Schleicher et al., 
1993; Ohkubo et al., 1995; Juraschek et al., 2012; Montagnana et al., 2013). After blood collection 
was complete, height and weight were measured with participants wearing no shoes using a 
balance-beam and a wall-mounted stadiometer, respectively. Then, participants ate a light 
breakfast. 
4.3.2 Comprehensive Questionnaire, Cognitive Testing and Laboratory Tour 
The health status questionnaire, modified from Robertson (2013) (Appendix B), was 
administered verbally in Punjabi by the bilingual author, and then, the author translated the 
answers into English and filled out the questionnaire. Participants self-reported their 
sociodemographic information, such as age, ethnicity, marital status, education level, employment 
status, as well as current and past health behaviors, such as alcohol intake and smoking status, and 
physical activity. In addition, each participant was asked about his or her personal and family 
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medical history, including current and past medical conditions, such as heart attack, stroke, 
diabetes, as well as neurological or other chronic disorders. Current medications (prescribed and 
over-the-counter) were also recorded, including the dosage and total years of medication use.  
Upon completion of the questionnaire, participants performed two computer-administered 
cognitive tasks: simple (sRT) and choice (cRT) reaction times. These tasks are classified as 
psychomotor tasks that involve attention and motor skills; sRT is considered a basic cognitive task 
that involves one stimulus and one response, whereas cRT is more complex because it requires 
decision-making to choose one of multiple responses depending on the stimulus presented. These 
tasks were chosen for this study because they are simple, culture-free assessments that have shown 
to be reliable when comparing between populations of different ethnic backgrounds (Hagger-
Johnson et al., 2014). For sRT task, participants were instructed to respond as fast as they could 
by pressing the button on the keyboard with the index finger when the letter ‘O’ appeared over the 
target in the middle of the computer screen; this was assessed for both the left and right index 
fingers.  For cRT task, participants were asked to respond with either their left or right index finger, 
depending on whether the target letter was ‘O’ or ‘X’. The sRT task was comprised of 8 sets of 
trials (4 trials for each finger), and the cRT was comprised of 4 sets of trials; each of these trials 
contained a total of 20 targets. Participants were given a practice trial before each task prior to the 
test trials. sRT and cRT reaction times were collected using E-Prime software (E-Prime, 
Psychology Software Tools Inc., Pittsburgh PA, USA). The tasks and trials within each task were 
automatically randomized by the software for every participant. 
After completing the cognitive tasks, participants were given a tour of the laboratory and an 
overview of the experimental protocol and equipment to relieve initial anxiety before proceeding 
with the experimental testing. This familiarization session was intended to reduce possible 
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physiological response to stress that could confound the cardiovascular variables during testing 
(Hickam et al., 1948). 
 
4.4 Part Two: Afternoon Session  
4.4.1 Overview 
The experimental test was performed at least 1-2 hours after breakfast to minimize the 
possible confounding effects of food consumption on cardiovascular measures. Room temperature, 
barometric pressure, and relative humidity were monitored during every test to ensure that 
environmental conditions were similar and maintained. Participants rested comfortably in supine 
position on an examination bed for at least 15 minutes before performing any assessment. During 
this time, they were instrumented for measurement of heart rate (HR), arterial blood pressure 
(ABP), exhaled CO2, cardiac output (Q), and blood flow velocity (BFV) at the right middle 
cerebral artery (MCA). These variables were recorded continuously throughout the entire test at 
1000 Hz using a data-acquisition system (PowerLab, ADInstruments, Colorado Springs CO, USA) 
and the corresponding computer software (LabChart 7, ADInstruments, Colorado Springs CO, 
USA). Once the signal quality of each device was optimized and stable, manual blood pressure 
was measured twice, one minute apart, using a sphygmomanometer to calibrate the Finometer 
blood pressures for offline analysis. Then, baseline vascular properties were examined: regional 
and central arterial stiffness were assessed by measuring brachial-ankle pulse wave velocity 
(baPWV) and CCA pulse pressure (PPcar), respectively; the arterial wall structure was examined 
by ultrasound measurements of CCA IMT; and the arterial wall function was evaluated by 
measurements of CCA compliance and distensibility. In addition, bilateral internal carotid artery 
(ICA) diameter and blood flow velocity were imaged using ultrasound to estimate aCBF. Lastly, 
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the participants were assisted in transitioning from supine to a seated position for the final 
assessment of cerebrovascular reactivity. 
4.4.2 Continuous Measurements 
While participants rested supine on the examination bed, they were instrumented with an 
electrocardiogram (ECG Module, Finapres Medical Systems, Amsterdam, NL) to measure HR 
using the CM5 electrode placement (the left and right shoulder below the collar bone, and the left 
fifth intercostal space). Beat-to-beat ABP (systolic blood pressure, SBP; diastolic blood pressure, 
DBP; and mean arterial pressure, MAP) were continuously measured on the left middle or index 
finger using a photoplethysmographic cuff from the Finometer (Finometer Pro, Finapres Medical 
Systems, Amsterdam, NL). Once stable signals were obtained, brachial artery pressure waveforms 
were reconstructed by the device from the finger waveforms via waveform filtering (transfer 
function) (Bos et al., 1996; Guelen et al., 2003). Additionally, the return-to-flow calibration on the 
device was performed to calibrate the finger pressure to brachial pressure by means of an 
automated upper arm cuff (Gizdulich et al., 1997). The height corrector was taped onto the 
participant at heart level to avoid the effect of hydrostatic pressure (Gizdulich et al., 1996). The 
Finometer also provided beat-to-beat estimates of Q based on a Modelflow algorithm.  
Breath-by-breath exhaled CO2 were collected through a nasal cannula and analyzed using 
infrared spectroscopy (Datex-Ohmeda 5200 CO2 Monitor, Mundelein IL, USA). The peak percent 
CO2 concentration at the end of every exhaled breath was used to represent end-tidal CO2 (ETCO2), 
and was converted to millimeters of mercury, mmHg, to be expressed as partial pressure of CO2 
(PETCO2). PETCO2 was calculated by multiplying the CO2 concentration by the difference in 
barometric and vapor pressure at room temperature. Changes in PETCO2 were used as a proxy for 
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changes in the partial pressure of arterial CO2 when cerebrovascular reactivity results were 
interpreted (Young et al., 1991). 
BFV at the right MCA was measured by transcranial Doppler ultrasound (TCD; Doppler 
Box, Compumedics DWL, Singen, GE) using a 2 megahertz (MHz) transducer. This method has 
been conventionally used in literature to assess global cerebral blood flow velocity since the MCA 
is one of the largest intracerebral vessels supplying a large proportion of the total blood flow to 
the brain (Schoning et al., 1994). The participants wore an adjustable headband (Marc 600, 
Spencer Technologies, Seattle WA, USA) that held the transducer steady on the right temporal 
region to insonate the M1 segment of the MCA throughout the test. At insonation depth between 
50 to 60 mm, the probe position and angle were adjusted accordingly to identify the MCA and to 
obtain the most optimal flow velocity signals directed toward the probe for each participant (Aaslid 
et al., 1982; Pellerito & Polak, 2012). 
4.4.3 Baseline Vascular Characteristics  
This section outlines the measurement techniques and the next section (Data Acquisition 
and Analysis) describes the equations and evaluation of these measurements. 
4.4.4 Brachial-Ankle Pulse Wave Velocity 
Pulse waves at the right brachial and posterior tibial arteries were recorded sequentially for 
20-30 cardiac cycles using pressure transducers (MLT1010, Pulse Transducer, ADInstruments, 
Colorado Springs CO, USA) placed directly on the surface of the skin and were used to compute 
baPWV. 
4.4.5 Carotid Pulse Pressure 
Beat-by-beat CCA pulse pressure (PPcar) was recorded non-invasively by applanation 
tonometry for 15-20 consecutive cardiac cycles (SPT-301, Millar Instruments, Houston TX, USA). 
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Briefly, the left CCA pulse was located by palpating the surface of the neck, and the hand-held 
tonometer probe was then placed directly over the center of the pulse with enough pressure to 
“flatten” the circumferential shape of the carotid artery against underlying adjacent tissue or bone. 
In this way, the probe recorded the internal pressure in the artery (Kelly et al., 1989). To obtain 
reliable carotid pulse signals, the hold-down pressure of the probe was adjusted accordingly until 
persistent maximum amplitude waveforms with a stable baseline appeared on the recording 
software on the computer screen (Drzewiecki et al., 1983). Ideally, the probe should be applied 
over the center of the vessel, and the vessel should be flattened. 
4.4.6 Carotid Arterial Wall Structure and Function 
Brightness-mode (B-mode) echo ultrasonography (M5 system, Mindray Bio-Medical 
Electronics Co., Shenzhen, CN) using an 8-12 MHz linear array transducer (L14-6s) was used to 
image the left and right CCA. The water-soluble ultrasonic gel was applied to the transducer that 
was placed against each participant’s neck to insonate the CCA within 1-2 cm of the carotid 
bifurcation. Images of the left and right CCA that captured the thickest part of the far arterial wall 
over 3 consecutive cardiac cycles were used for mean and maximum IMT measurement. IMT was 
defined as the distance from the lumen-intimal interface to the media-adventitial interface of the 
far wall of the artery (Touboul et al., 2006). ECG signals were simultaneously recorded on the 
images and used for data analysis purposes. In addition, the B-mode images of the left CCA were 
used, in combination with PPcar, to calculate arterial compliance and distensibility (See Data 
Acquisition and Analysis for further details). 
4.4.7 Cerebral Blood Flow 
Extracranial blood flow through bilateral ICA was estimated using duplex ultrasonography 
(M5 system). For diameter measurements, the 8-12 MHz linear array transducer was used to 
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collect longitudinal B-mode images of the ICA at least 1-2 cm distal to the carotid bifurcation; for 
velocity measurements, a beat-to-beat spectral velocity trace was collected using Doppler mode 
(PW-mode). The sample volume for the velocity trace was taken from the same location as the 
vessel diameter measurements. The sample volume cursor was positioned in the center of the 
vessel, parallel to the wall, and its gate was adjusted to encompass the full width of the vessel 
diameter. The angle of insonation (angle between the direction of the ultrasound beam and the 
direction of blood flow) was kept at or less than 60 degrees. The vessel diameter and velocity 
measurements were used to calculate the mean blood flow (CBF) in both the left and right ICA, 
and the bilateral sum of the CBF volumes was used to calculate aCBF (Equation 1.11, See Data 
Acquisition and Analysis section for further details). 
4.4.8 Cerebrovascular Reactivity to Carbon Dioxide 
After participants transitioned from supine to a seated position, cerebrovascular reactivity to 
hypocapnia (LOWCO2) and hypercapnia (HICO2) were examined. In preparation for these 
assessments, a 5-litre non-diffusing gas bag (Series 6000, Hans Rudolph, Shawnee KS, USA) was 
inflated with a gas mixture (5% CO2, 21% O2, and balance N2). Then, the bag was attached to a 
breathing tube connected to a mouthpiece.  
After a 5-minute rest in the seated position, manual blood pressure was again measured twice 
for the purpose of calibrating the Finometer blood pressure signals in this posture before beginning 
the assessment. Then, the nasal cannula was removed and replaced with a nose clip and a 
mouthpiece sealed air tight. In addition, the sampling line from the CO2 monitoring device was 
attached to the mouthpiece. A three-way valve (Three-way T-shape Stopcock Type, Hans 
Rudolph, Shawnee KS, USA) on the bag was used to manually switch between the delivery of 
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room air and hypercapnic gas during the assessment. Beat-to-beat recordings of ABP, PETCO2, 
and BFV at the MCA were simultaneously recorded for data analysis of cerebrovascular reactivity. 
The assessment began with each participant breathing room air for 3 minutes through the 
mouthpiece at their normal breathing rate to obtain baseline values, followed by the induction of 
hypocapnia achieved through mild hyperventilation. Participants were instructed to hyperventilate 
for 2 minutes to reduce PETCO2 ~5-10 mmHg from their baseline. Their breathing rate was paced 
by using an electronic metronome (Seiko Digital Metronome 440 Hz) set at a frequency of 20 
breaths per minute. Then, participants returned to their normal breathing rate while continuing to 
breathe through the mouthpiece for 3 minutes to recover from hyperventilation before proceeding 
to the second condition (hypercapnia). To achieve hypercapnic conditions, first the bag-valve was 
switched from room air to the gas mixture contained in the bag. Participants then inhaled the gas 
for 3 minutes and were told to maintain a constant breathing frequency. Based on the pre-
established threshold for obtaining adequate signal-to-noise ratio of BFV signals from the TCD, a 
minimum of ~5 mmHg increase and decrease in PETCO2 were sufficient to induce hypercapnic and 
hypocapnic conditions, respectively (Robertson, 2013). ETCO2 and BFV signals on the computer 
screen were closely monitored to ensure these thresholds were being met and maintained during 
each condition. The assessment ended when the valve was turned back to room air. 
After the entire study procedure was complete, all equipment and devices were removed 
from the participants, and waist and hip circumference were the final measurements. While 
participants stood still, waist circumference was measured using a measuring tape between the 
costal margin and iliac crest at the end of a normal expiration, and hip circumference was measured 
around the widest portion of the buttocks. 
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4.5 Data Acquisition and Analysis 
4.5.1 Biochemical Analysis 
Blood samples obtained from each participant were collected in plain tubes (for whole 
blood and serum analyses) and in Ethylenediaminetetraacetic acid (EDTA) anticoagulant-treated 
tubes (for plasma analysis). Immediately after collection, one plain tube containing the whole 
blood sample was analyzed for fasting glucose (Glucose: Accu-Chek Aviva, Roche, Mannheim, 
DE, USA); HbAlc (A1cNow+, Bayer Health Care, Sunnyvale CA, USA); and hematocrit 
(microcapillary tube centrifugation at 1000 rounds per minute (rpm) for 5 minutes). The remaining 
tubes containing the blood sample were put in dry ice, after which they were centrifuged at 2800 
rpm for 15 minutes at room temperature in order to separate the serum in the plain tubes and the 
plasma in the EDTA-treated tubes. The serum and plasma were carefully transferred into separate 
Eppendorf tubes using a pipette and then stored in a -80°C freezer.  
Commercially available assay kits were used to analyze fasting plasma levels of glycated 
albumin (Human Glycated Albumin ELISA Kit [Order No. E01G0293], Bluegene SA, China) and 
CRP (CRP sensitiv [Cat. No. K9710s], ALPCO Immunoassays, Salem NH, USA), as well as 
serum levels of insulin (Insulin Coat-A-Count Kit [Cat. No. TKIN1], Seimens Medical Solutions 
Diagnostics, Los Angeles CA, USA); triglycerides (Triglycerides-GPO Reagent Set, Pointe 
Scientific, Inc., Canton MI, USA); total cholesterol (Cholesterol Reagent Set, Pointe Scientific, 
Inc., Canton MI, USA); high-density lipoproteins (HDL) and low-density lipoproteins (LDL) 
(HDL Cholesterol Precipitating Reagent Set, Pointe Scientific, Inc., Canton MI, USA). Insulin (in 
microunits per millilitre, μU/mL) and glucose (in millimole per litre, mmol/L) levels were used to 
estimate insulin resistance using the Homeostasis Model of Assessment - Insulin Resistance index 
(HOMA-IR, Equation (1.1)). In current literature, this equation is considered a feasible and 
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reliable surrogate measure of insulin sensitivity as it has been previously validated with the golden 
standard euglycemic-hyperinsulinemic clamp techniques in humans (Matthews et al., 1985; 
Bonora et al., 2000).  
 
 
4.5.2 Anthropometric Calculations 
Height (in meters, m) and weight (in kilograms, kg) were used to calculate body-mass 
index (BMI; Equation (1.2)). These measurements were also used in the Dubois and Dubois 
formula to estimate body surface area (BSA; Equation (1.3)) to correct Q for body size. 
 
 BMI (kg/m2) = weight (kg) / height (m)2 (1.2)  
 BSA (m2) = 0.007184 · weight (kg)0.425 ·  height(cm)0.725 (1.3)  
Waist and hip circumference measurements (in cm) were assessed individually and as a 
waist-to-hip ratio (WHR; Equation (1.4)). 
 
 WHR =  Waist Circumference (cm) / Hip Circumference (cm)                  (1.4)  
4.5.3 Cardiovascular Variables 
All cardiovascular variables were expressed as an average over the last 30 seconds in each 
position (supine and sit) and in each condition during cerebrovascular reactivity. As previously 
mentioned in the methods section, manual measurements of blood pressure using the traditional 
auscultation method were performed 5 minutes after participants rested in supine and seated 
 HOMA-IR =  [fasting insulin (μU/mL) · fasting glucose (mmol/L)] / 22.5 (1.1)  
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positions to compare and correct the blood pressure readings from the Finometer since this device 
has the tendency to overestimate systolic pressure readings (Rongen et al., 1995) During offline 
analysis, the time point when manual BP were measured, simultaneous BP readings from the 
Finometer were averaged over 15 beats, and if the BP values differed between the two methods by 
> 10 mmHg, then the BP readings from the Finometer were corrected to the manual BP values. 
 Q (in litres per minute, L/min) was estimated by the Modelflow algorithm from the 
Finometer device. The Modelflow algorithm uses the three-element Windkessel model to compute 
an aortic flow waveform and estimate stroke volume. The three elements represent the major 
properties of the arterial system: aortic impedance, arterial compliance, and systemic (peripheral) 
vascular resistance. Aortic impedance and compliance depend on the elastic properties of the aorta 
and are estimated from the non-linear aortic pressure-area relationship, which was an empirical 
model originally studied/derived from post-mortem human aortas (Langewouters et al., 1984). For 
each ABP waveform, values for these parameters are computed and then used in the algorithm that 
takes into account each participant’s age, gender, height and weight to estimate beat-to-beat Q. Q 
for each participant was corrected for body size by computing a cardiac index (Qi; Equation (1.5)) 
 
 Qi (L/min/m
2) =  Q (L/min) / BSA (m2) (1.5)  
Beat-by-beat total peripheral resistance (TPR, mmHg/L/min) was calculated as MAP, 
generated from the Finometer at heart level, divided by Q in Equation (1.6) below: 
 
 TPR (mmHg/L/min) = MAP (mmHg) / Q (L/min) (1.6)  
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4.5.4 Brachial-Ankle Pulse Wave Velocity 
Rather than the gold standard carotid-femoral PWV method, baPWV was an alternative 
method used that reflects the stiffness of both central and peripheral muscular arteries. The key 
advantage of the baPWV method was that it was an appropriate method that respects the comfort 
level of older participants in a research laboratory setting compared to carotid-femoral PWV 
method. baPWV has a modest correlation with carotid-femoral PWV (Yu et al., 2008; Tanaka et 
al., 2009) and has been validated and shown to be a reproducible measure (Yamashina et al., 2002). 
Other studies have found that baPWV and carotid-femoral PWV are associated with similar 
cardiovascular disease risk factors and clinical cardio- and cerebrovascular events (Turin et al., 
2010; Vlachopoulos et al., 2010; Ninomiya et al., 2013). Therefore, baPWV was a reasonable 
surrogate marker of arterial stiffness in this study. 
The anatomic distance from the suprasternal notch to each arterial site (brachial artery, Lb, 
and posterior tibial artery, La) was measured using a tape measure, as previously performed in CA 
group (Robertson, 2013). The difference between these measured distances was used in Equation 
(1.7) to calculate baPWV (in metres/second, m/s). In addition, a digital low-pass filter with a 
maximum cut-off frequency of ~20 Hz was applied to the recorded signals to reduce the noise and 
distortion in the original arterial pressure waveforms, thereby improving the signal-to-noise ratio 
(Goldberger & Ng, 2010). Then, the average transit time for brachial (Tb) and posterior tibial (Ta) 
arteries were measured from the foot of the pressure pulse waveforms gated to the R-spike of the 
ECG over the last 25-30 cardiac cycles of recording. The foot of each waveform was identified as 
the minimum point just before the initial systolic upstroke of the wave. 
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 baPWV (m/s) = [La – Lb] / [Ta – Tb] ,    (1.7)  
where La and Lb are the distances (in metres, m) from the suprasternal notch to the posterial tibial 
and brachial artery, respectively. Ta and Tb are the average times (in seconds, s) from the R-spike 
to the foot of the wave at the posterial tibial and brachial artery, respectively. 
 
 
4.5.5 Carotid Pulse Pressure 
CCA pulse waveforms (expressed in volts, V) measured by applanation tonometry using the 
Millar transducer was converted into pressure waveforms (in mmHg) by calibrating them to the 
brachial MAP and DBP measured from the Finometer. This is a method originally proposed by 
Kelly et al., (1989), and is based on the concept that MAP and DBP do not change considerably 
along the arterial tree; invasive studies have shown that MAP and DBP from the central to 
peripheral arteries differ only slightly (Schnabel et al., 1952; Kroeker & Wood, 1955; Pauca et al., 
1992). The average MAP and DBP values simultaneously recorded from the Finometer during the 
assessment were used to estimate PPcar. Carotid SBP was calculated by extrapolation to the peak 
of each carotid pulse wave. Therefore, to ensure the accuracy of PPcar measurements, the brachial 
artery pressure waveforms had to be reconstructed by the Finometer device and manual blood 
pressure was taken prior to the assessment. PPcar was computed as an average over a minimum of 
15 consecutive beats when the pressure waveforms had a stable baseline, and the maximal 
amplitude was consistent among the waveforms recorded. 
4.5.6 Carotid Intima-Media Thickness 
Mean and maximum IMT were measured on B-mode longitudinal ultrasound images of the 
CCA obtained from both sides of the neck. A set of 8 electronic calipers were equally placed over 
a 1-cm segment along the far wall of the artery on frozen images during diastole (at the R-spike 
on the ECG signals), and an average was taken over 3 consecutive beats. The mean IMT (in 
30 
 
millimeters, mm) was computed by combining the average IMT measurements from the left and 
right CCAs. Similarly, the thickest wall of the left and right CCAs were averaged to calculate the 
maximal IMT. Reporting the average CCA IMT measurements from both sides as opposed to one 
side only is believed to be reproducible and more precise, as inter-observer errors are low (Schmidt 
& Wendelhag, 1999). 
4.5.7 Carotid Compliance and Distensibility 
The left CCA systolic and diastolic diameters were measured from longitudinal B-mode 
images. Calipers were used in triplicates to measure from the top wall intima to bottom wall intima, 
perpendicular to the vessel, over 3 consecutive cardiac cycles. Systole and diastole were 
determined as the largest and smallest diameters during the cardiac cycle. An average diameter 
value for each phase, along with the calculated average PPcar, were used to calculate distensibility 
coefficient (DC) (Equation (1.8)) and compliance coefficient (CC) (Equation (1.9)) (Van Bortel 
et al., 2002; Reneman et al., 2005). 
 
 CC (mm2/MPa) = [π • ΔD(mm) • D(mm)] / [2 • PPcar (MPa)] (1.8)  
 DC (10-3/kPa) = [2 • ΔD(mm) • D(mm) + ΔD(mm)2] / [D(mm)2 • PPcar (kPa)] (1.9)  
4.5.8 ICA Blood Flow and Anterior Cerebral Blood Flow 
The left and right ICA mean blood flow volumes were determined as the product of the 
average cross-sectional area of the blood vessel and the mean flow velocity (MFV, in cm/s) using 
Equation (1.10)). The diameter was measured during end-diastole (gated to the R-spike) in 
triplicates using electronic calipers on B-mode images that were averaged over 3 consecutive 
cardiac cycles. MFV was obtained from the PW mode images by averaging the velocity over 4-5 
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consecutive cardiac cycles. aCBF (in mL/min) was computed as the sum of the left and right ICA 
blood flow volumes (Equation (1.11)). 
 
 ICA Blood Flow (mL/min) =  [MFV (cm/s) ∙ π ∙ diameter (cm)2 / 4] ∙ 60 s/min (1.10)  
 aCBF (mL/min)= left ICA CBF + right ICA CBF   (1.11)  
4.5.9 Indices of Cerebrovascular Function 
Cerebrovascular function was evaluated by measuring the change in MCA MFV from the 
TCD in response to the change in PETCO2. Several studies have described a linear relationship 
between TCD-measured MFV at the MCA and PETCO2 (Hauge et al., 1980; Peebles et al., 2007; 
Ainslie & Duffin, 2009; Zuj et al., 2012), whereas others have argued a non-linear relationship 
(Ide et al., 2003). For the present study, a linear relationship was assumed in order to compare 
reactivity between ethnic groups. The mean values of MFV and PETCO2 at baseline, hypocapnia, 
and hypercapnia were obtained from averaging the last 30 cardiac cycles of data in each condition 
and were used to calculate cerebrovascular reactivity to hypocapnia (LOWCO2, Equation (1.12) 
and (1.13)) and hypercapnia (HICO2, Equation (1.14) and (1.15)). Cerebrovascular reactivity for 
each condition was expressed as an absolute and as a percent change in MFV from baseline 
(breathing room air at a normal breathing rate) over the mmHg change in PETCO2 (Ide et al., 2003; 
Cummings et al., 2007; Peebles et al., 2007). Furthermore, ABP was continuously recorded during 
the assessment to monitor its potential effects on MFV values (Dumville et al., 1998; Hetzel et al., 
1999; Panerai et al., 1999; Edwards et al., 2002; Battisti-Charbonney et al., 2011). 
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 LOWCO2 (Δcm/s/ΔmmHg) = [MFV(hypocapnia) – MFV(baseline)]  
                                                [(PETCO2(hypocapnia) – PETCO2(baseline)] 
(1.12)  
 LOWCO2 (Δcm/s/ΔmmHg) = [MFV(hypocapnia) – MFV(baseline)] / MFV(baseline)  · 100 % 
                                               [(PETCO2(hypocapnia) – PETCO2(baseline)] 
(1.13)  
 HICO2 (Δcm/s/ΔmmHg) =   [MFV(hypercapnia) – MFV(baseline)]  
                                              [(PETCO2(hypercapnia) – PETCO2(baseline)] 
(1.14)  
 
 
HICO2 (Δcm/s/ΔmmHg) = [MFV(hypercapnia) – MFV(baseline)] / MFV(baseline)  · 100 % 
                                                [(PETCO2(hypercapnia) – PETCO2(baseline)] 
(1.15)  
4.5.10 Cerebrovascular Hemodynamic Properties 
MCA flow velocity waveforms derived from the TCD waveform signals, including peak-
systolic (SFV) and end-diastolic (DFV) flow velocities, were used to compute indices that describe 
cerebrovascular hemodynamics and regulation. Pourcelot’s resistance index (RI, Equation (1.16)) 
was used to reflect the resistance to flow of downstream cerebral microvessels. Gosling’s 
pulsatility index (PI, Equation (1.17)) was used to describe the pulsatile blood flow pattern in the 
cerebral vessels that is dependent on the downstream resistance of microvessels in the brain. 
 
RI =  [SFV (cm/s) – DFV(cm/s)] / SFV (cm/s) (1.16)  
PI =  [SFV (cm/s) – DFV (cm/s)] / MFV (cm/s) (1.17)  
An additional index of cerebrovascular resistance (CVRi) was examined to account for the 
influence of ABP on MFV, which is ignored in RI and PI calculations. Cerebrovascular resistance 
is traditionally calculated as the ratio between cerebral perfusion pressure (CPP) and CBF. CPP is 
the pressure that drives blood flow to the brain, and is calculated as the difference between 
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systemic ABP (MAP) and intracranial pressure (ICP). Unfortunately, ICP measurements often 
require invasive methods, which is impractical in the present study. In healthy individuals, ICP is 
described as being low and relatively stable; therefore, the contribution of ICP to CPP is much 
smaller relative to MAP. For this reason, and in accordance with relevant studies, ICP was assumed 
to have a negligible impact on CPP, and thus MAP was used to represent CPP when determining 
CVRi (Liu et al., 2005; Panerai et al., 2005; Robertson et al., 2010; Robertson, 2013). 
 Supine CVR for each participant was computed by taking the average MAP over the last 
30 beats in that position and the measured aCBF value (Equation (1.18)). In addition, an index of 
CVR, CVRi, for each position and each condition of cerebrovascular reactivity was computed by 
taking the average MAP and MFV over the last 30 beats. MFV was used to represent CBF when 
computing CVRi under the assumption that the MCA diameter remained constant. The majority 
of research provides convincing evidence that MFV is a reliable index of CBF (Valdueza et al., 
1997; Schreiber et al., 2000). Some studies have confirmed that MCA diameter does not change 
in different conditions, such as during hyperventilation when PETCO2 is decreased (hypocapnia) 
or when PETCO2 increases (hypercapnia). In addition, others have shown that changes in MFV 
correlate with changes in CBF (Bishop et al., 1986; Sorteberg et al., 1989; Egashira et al., 1994; 
Clark et al., 1996). Therefore, supine CVRi was calculated using Equation (1.19)), and supine 
CVR was calculated using aCBF in place of MFV. Seated CVRi was calculated by first correcting 
MAP to the height level of the MCA (MAPMCA) to account for the hydrostatic pressure gradient 
in head-up positions (Equation (1.20)). 
 
 CVR (mmHg/mL/min) = MAP (mmHg) / aCBF (mL/min) (1.18)  
 CVRi (mmHg/cm/s) =  MAP (mmHg) / MFV (cm/s) (1.19)  
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 CVRi (mmHg/cm/s) =  MAPMCA (mmHg) / MFV (cm/s), where (1.20)  
 MAPMCA (mmHg) = MAP (mmHg) – [0.78 ∙ mmHg/cm ∙ distance from heart to TCD probe (cm)] 
4.5.11 Classification and Quantification of Physical Activity Level 
Each participant’s current physical activity level was assessed using both self-reported data 
and direct measures. Self-reported physical activity, derived from the health status questionnaire, 
was scored and entered into one of three categories: Inactive, active, or highly active lifestyle 
(Refer to Appendix C for the scoring guideline). Direct measures of physical activity were 
obtained from the SenseWearTM armband (SWA) (SenseWearTM Body Monitoring System, 
BodyMedia Inc., Pittsburgh PA, USA). Validation studies of SWA in different populations have 
been published (Fruin & Rankin, 2004; St-Onge et al., 2007), including in older adults (Mackey 
et al., 2011). This device is a two-axis accelerometer with multiple sensors that monitor heat flux, 
skin conductivity, and skin temperature (Jones et al., 2011). These measures, in combination with 
the participants’ demographic information (age, gender, height, weight, smoking status, and 
handedness), were processed in an algorithm carried out by the accompanying analysis software 
(The SenseWearTM Professional Software) to provide minute-by-minute estimates of energy 
expenditure (EE) during awake and sleep states and during different levels of physical activity. 
After each armband was returned, data were uploaded to a computer and exported into Microsoft 
Excel. The time period selected for data output was three days since previous studies have found 
that three-day scores provide an accurate estimate of EE in older adults (Hart et al., 2011; Mackey 
et al., 2011). 
SWA was used to make quantitative estimates of physical activity, which included number 
of steps, energy expenditure from activities of daily living (AEE), and physical activity EE 
(PAEE), all expressed as daily averages. Total EE (TEE) is composed of basal metabolic rate 
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(BMR), thermal effects of food (TEF), and AEE (Insel et al., 2003; Colbert et al., 2011; Tanhoffer 
et al., 2012). Therefore, AEE was calculated using Equation (1.21), where TEE was obtained 
from the SWA (TEESW); BMR was represented by the sleeping metabolic rate, which was 
calculated by taking the mean of the average EE over the last 60 minutes prior to waking each 
morning (Heiermann et al., 2011); and TEF was considered 10% of daily TEE (Vaughan et al., 
1991; Westerterp, 2004; Middleton et al., 2011). PAEE was defined as the amount of energy 
expended by physical activities ≥ 3 METs (AEESW) over the amount of time spent exercising. 
AEESW was user defined by setting the METs threshold level on the SWA analysis software. PAEE 
was corrected for BMR; that is, the BMR was not considered part of EE from physical activity 
(Equation (1.22)). 
 
 AEE (kcal/day) = TEESW (kcal/day) – BMR (kcal/day) – TEF (kcal/day) ,   
where TEF = 0.1∙ (TEESW) 
(1.21)  
 PAEE (kcal/day) = [AEESW (kcal/min) – (BMR (kcal/min) ∙ PAtime (min))] ∙ day/60 min , 
where PAtime is the duration of physical activity 
(1.22)  
4.5.12 Reaction Time Tasks 
sRT and cRT were analyzed using the E-DataAid software program. A cutoff range of <100 
and >1000 ms were used to eliminate trials where participants seemed to be anticipating a response 
rather than reacting to the target or not be paying attention to the target. An overall average sRT 
and cRT were calculated over all the trials for the left and right index fingers. In addition, the 
coefficient of variance (defined as the standard deviation divided by its mean and expressed as a 
percentage) was also computed for each individual, and then a group average was determined to 
compare the relative intra-individual variability in reaction times between the groups. 
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5 Statistical Analysis 
 Normality probability and histograms were created for each continuous variable to 
determine whether the requirements of the normality assumption were satisfied for the measured 
variables used in the statistical tests outlined below. Non-normal data were either natural-log or 
square root transformed accordingly. Parametric tests were employed and all statistical tests were 
considered significant at a significance level of p≤0.05, while trends were reported at 0.05 ≤ p ≤ 
0.10. Statistical data analyses and graphs were completed using SigmaStat 12.5 (Systat Software 
Inc., Chicago, IL, USA). CA and SA group mean differences of continuous variables were 
compared using two-tailed t-tests and were presented as mean ± standard deviation. Categorical 
variables (demographics, health status, medications, smoking and drinking status) were compared 
using z-tests and presented as frequency (%). Differences in baseline cardio- and cerebrovascular 
variables between ethnic groups prior to the cerebrovascular reactivity assessment were evaluated 
using unpaired t-test. The change (i.e., delta, Δ) in these variables from baseline condition to 
hypocapnia and to hypercapnia were also compared between groups using two-tailed t-test. 
Pearson product correlations and multivariate linear regression analyses were used to examine the 
association between indicators of arterial stiffness and aCBF. Ethnic status (0=CA, 1=SA) and an 
interaction term between ethnic status and arterial stiffness were added into the model as an 
independent variable to assess whether ethnic status modifies the association. If the interaction 
term was statistically significant (p<0.05), then stratified (by ethnic group) linear regressions were 
performed to test how much the relationship between differed between CA and SA ethnic groups. 
 Secondary analyses included performing Pearson product correlations to explore 
relationships between measures of central arterial structure and function, cerebrovascular 
hemodynamics (MFV, CVR, CVRi, RI and PI), performance on cognitive tasks (sRTs and cRTs), 
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and measures of physical activity obtained from the SensewearTM armband monitoring device in 
each ethnic group. Significant relationships observed in each ethnic group between measures of 
arterial structure and function and cerebrovascular hemodynamics were further explored in linear 
regression models to determine whether the relationships differed between the two ethnic groups. 
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6 Results 
6.1 Participant Characteristics 
 The characteristics of the study participants, separated by ethnic group, were presented in 
Table 1. The mean age of the participants in each group was 71 years, ranging from 64 to 82 years. 
SA participants were all born outside of Canada (n=22), whereas over a quarter of CA group were 
immigrants (n=6). No significant differences were detected between the two ethnic groups with 
respect to weight, BMI, and hip circumference, although SA participants had larger WHR 
(p=0.003) and waist circumference (p=0.006) compared to CA participants. SA participants were 
also shorter (p=0.027) and had smaller body surface area (p=0.033) than CA participants. Both 
ethnic groups were comprised of a greater proportion of participants who were married; however, 
there were more divorced (p=0.028) and widowed participants (p=0.051) in CA group compared 
to SA group. Education level was significantly different between the groups, where CA 
participants had more years of education than SA participants (p<0.001). More SA participants 
were without a high school diploma (p=0.018), and very few had attained post-secondary 
education or higher (p=0.003) compared to CA group. All SA participants were non-smokers, 
whereas just under a half of the CA group were current smokers (p=0.006). In addition, alcohol 
consumption was greater in CA group than SA group (p<0.001).  
 No significant differences in medical conditions were noted; the prevalence of 
hypertension and hyperlipidemia were similar across the two groups. Two SA participants had 
reported to have diabetes. Furthermore, no differences were seen between CA and SA group for 
metabolic syndrome, which was characterized in accordance to the American Heart Association 
diagnostic criteria for metabolic syndrome (Grundy et al., 2005). The prevalence of other relevant 
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cardiovascular risk factors, including family history of cardiovascular diseases, stroke and 
hypertension, were not significantly different between CA and SA group. 
 Several notable differences in blood markers were detected between the two ethnic groups 
(Table 2). Fasting glucose levels were lower in SA group compared to CA group (p=0.031), but 
conversely, SA group had significantly higher HbA1c (p<0.001). These differences still remained 
significant even after excluding the two diabetics in SA group (Glucose: CA: 5.39 ± 0.48 mM 
(n=22), SA: 4.96 ± 0.72 mM (n=20), p= 0.027; HbA1c: CA: 5.29 ± 0.38 % (n=22), SA: 5.88 ± 0.60 
% (n=20), p<0.001). Levels of HDL and LDL were also higher in SA group compared to CA group 
(p=0.006 and p=0.013, respectively). No differences in average hematocrit, TG, total cholesterol, 
TC/HDL ratio, and CRP inflammatory marker were detected between the groups. Levels of 
glycated albumin, insulin, and HOMA-IR were evaluated in SA group, but not previously in the 
CA group; therefore, no t-tests were performed for these markers. The self-reported use of 
prescription medications, specifically antihypertensive, antithrombotic and antiinflammatory 
drugs, was similar across the two groups (Table 3). The number of CA participants taking vitamin 
D supplement was significantly higher than SA group (p=0.032). 
 
6.2 Physical Activity 
 Physical activity profiles for CA and SA group determined by subjective and objective 
methods were presented in Table 4. Three CA participants did not complete the questionnaire. 
SWA data were not available for 2 SA participants, and data collected over 2 consecutive days as 
opposed to three days were available in 2 CA participants and 7 SA participants due to technical 
difficulties that prevented complete data collection. However, the number of days did not 
significantly influence the data, given that no differences were observed for total energy 
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expenditure per day and daily number of steps between participants with two-day and three-day 
SWA data in each group (CA: p=0.198, p=0.819; SA: p=0.231, p=0.979, respectively, 
APPENDIX D, Supplementary Table 1). Therefore, participants who wore the armband for at 
least 48 hours and for at least 90% of that time were used to analyze physical activity. In addition, 
no differences in physical activity were found between participants whose SWA data collection 
period included the weekend and those whose data were collected on weekdays only (APPENDIX 
D, Supplementary Table 2). A significant difference in the level of physical activity was found 
between the study groups; more CA participants were highly active compared to SA participants 
(p<0.001). No CA participant was physically inactive; conversely, more than half of the 
participants in the SA group were inactive (p<0.001). Similarly, quantitative data obtained 
objectively from SWA revealed that the number of steps per day was significantly greater in CA 
group than SA group (p=0.006). Although differences in daily METs, AEE, PAEE, and the 
duration of physical activity were not detected, CA group generally engaged in more high-level 
intensity activities compared to SA group, and thus, tended to expend more energy (TEE) 
(p=0.096).  
 When data only from participants who had three complete days of SWA were analyzed 
(i.e., participants who wore the SWA for less than three consecutive days were removed from the 
analysis), the differences between CA group and SA group still remained, where the average daily 
steps were significantly lower in SA group (CA: 8052 ± 2651; SA: 5636 ± 2665, p=0.016).  
 
6.3 Cognitive Performance Outcomes 
 Natural log-transformed average reaction time scores for sRT and cRT tasks by ethnic 
group were presented in Table 5. Compared to CA participants, SA participants had significantly 
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slower sRT and cRT for both the left and right index fingers. Although the standard deviations 
appeared to be larger in SA group compared to CA group, the coefficient of variance was not 
different between the groups; in other words, the intra-variability in response time from trial-to-
trial for each participant was similar for both groups. Pearson correlation analyses of the total study 
sample showed that faster log-transformed RTs were closely related to greater years of education 
(right index finger sRT: r= -0.683, p<0.001; left index finger sRT: r= -0.66, p<0.001; right index 
finger cRT: r= -0.59, p<0.001; left index finger cRT: r= -0.53, p<0.001). After controlling for years 
of education as a covariate in the analysis of variance, differences in RTs between the groups 
remained significant (Right sRT: p<0.001; left sRT: p=0.0025; right choice RT: p=0.0035; left 
choice RT: p<0.001).  
 
6.4 Arterial Structure and Function and Cerebral Blood Flow 
 The measurements of arterial stiffness, structural and functional arterial properties, and 
cerebral blood flow by ethnic group are presented in Table 6. PPcar was significantly higher in SA 
participants compared to CA participants (CA: 46 ± 10 mmHg; SA: 59 ± 18 mmHg, p=0.005), and 
a trend for faster baPWV was also observed in SA participants (CA: 11 ± 2 m/s; SA: 12 ± 2 m/s, 
p=0.080). Mean carotid IMT tended to be lower in SA participants than in CA participants 
(p=0.073), and maximum (or peak) IMT were significantly higher in CA participants than in SA 
participants (p<0.001). Conversely, carotid compliance was significantly lower in SA participants 
(p=0.048). In addition, SA participants appeared to have lower carotid distensibility compared to 
CA participants, although this did not reach statistical significance (p=0.109).  
 A trend was observed for SA group to have higher right ICA (CA: 268 ± 76 mL/min; SA: 
349 ± 153 mL/min, p=0.062) and anterior CBF (aCBF) (CA: 536 ± 134 mL/min; SA: 660 ± 233 
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mL/min, p=0.065) compared to CA group, although not statistically significant. Higher blood flow 
velocity (MFV) through the right ICA observed among SA participants (p=0.046). The left ICA 
MFV also appeared to be higher in SA group, but it was not statistically significant (p=0.140). No 
differences were observed in the ICA diameters between the two groups. Furthermore, no within-
group differences in MFV and diameter were observed between the left and right ICA. 
 
6.5 Cerebrovascular Hemodynamic and Cardiovascular Variables in Supine and 
Seated Rest Positions 
 The cerebrovascular and cardiovascular variables in resting supine and seated postures are 
presented in Table 7. TCD data was not collected in 7 SA participants during supine and 6 SA 
participants during seated positions due to poor transparency of the ultrasonographic temporal 
bone windows. During the supine assessment, SFV in the MCA tended to be higher in SA group 
compared to CA group (p=0.063); this difference became statistically significant in the seated 
position (p=0.030). In addition, DFV, MFV, RI and PI in both supine and seated positions appeared 
to be elevated in SA group, but they did not achieve statistical significance. A trend for lower CVR 
was noted in SA group compared to CA group (p=0.063). Furthermore, SA group had lower DBP 
(p=0.017) and TPR (p=0.035), and higher Qi (p=0.003) in the supine position compared to CA 
group, but these differences were not evident in the seated position. No differences were found in 
HR, SBP and MAP between the two ethnic groups in either position. Of note, PETCO2 was 
significantly higher in SA group compared to CA group in both the supine (CA: 37 ± 3 mmHg; 
SA: 41 ± 3 mmHg, p<0.001) and seated positions (CA: 36 ± 4 mmHg; SA: 40 ± 4 mmHg, 
p=0.005).  
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6.6 Cerebrovascular Reactivity to Carbon Dioxide 
 Cerebrovascular reactivity to CO2 evaluated under hypocapnic and hypercapnic conditions 
is presented in Table 8. The absolute and relative change in MFV per change in PETCO2 were 
calculated in each condition. No differences in cerebrovascular reactivity to CO2 between the two 
groups were found. 
 The cerebrovascular and cardiovascular responses to hypocapnia and hypercapnia for CA 
and SA group are illustrated in Figure 2. Both groups began the cerebrovascular reactivity 
assessment during baseline at similar MFV (CA: 50 ± 12 cm/s; SA: 57 ± 17 cm/s, p=0.130), CVRi 
(CA: 1.53 ± 0.53; SA: 1.44 ± 0.36, p=0.553), HR (CA: 66 ± 10 bpm; SA: 67 ± 11 bpm, p=0.814), 
MAP (CA: 100 ± 10 mmHg; SA: 104 ± 19 mmHg, p=0.396), and PETCO2 (CA: 37 ± 4 mmHg; 
SA: 39 ± 5 mmHg, p=0.116). In hypocapnic condition, the response was similar in both groups; 
MAP, PETCO2 and MFV decreased, whereas HR and CVRi increased from baseline. In 
hypercapnic condition, SA group exhibited a greater increase in PETCO2 (CA: +9 ± 2 mmHg; SA: 
+12 ± 5 mmHg, p=0.011) and MFV (CA: +17 ± 7 cm/s; SA: +25 ± 13 cm/s, p=0.022) compared 
to CA group. The absolute change in HR (CA: +0.6 ± 3; SA: +1.8 ± 4), MAP (CA: +10 ± 8 mmHg; 
SA: +12 ± 6 mmHg) and CVRi (CA: -0.22 ± 0.22 mmHg/cm/s; SA: -0.26 ± 0.18 mmHg/cm/s) 
from baseline were not different between the two groups during hypercapnic conditions. 
 
6.7 Relationships with Arterial Structure and Function and Cerebrovascular 
Hemodynamic Properties 
 A linear relationship between age and arterial stiffness (baPWV) was observed in both CA 
(r=0.47, p=0.029) and SA groups (r=0.44, p=0.045) (Figure 3); this relationship was not different 
between the groups (ethnicity*age interaction term: β=0.05, p=0.654, adjusted R2=0.20). 
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Furthermore, a linear trend was noted between age and reduced aCBF in the total sample (r= -0.26, 
p=0.098, Figure 4), but this relationship was not seen when the groups were examined separately 
(CA: r= -0.12, p=0.626; SA: r= -0.34, p=0.118). 
 A linear regression analysis revealed that baPWV was not a significant predictor of the 
log-transformed aCBF in the study groups (CA: adjusted R2=0.11, β=0.03, p=0.086; SA: adjusted 
R2=0.00, β=0.01, p=0.376) (Figure 5). In addition, when the interaction term between ethnicity 
and baPWV was entered into the regression model for log-transformed aCBF as a function of 
baPWV, it was not significant; that is, the effect of ethnicity on this relationship was not significant 
(ethnicity*baPWV interaction term: β= -0.02, p= 0.433, adjusted R2=0.10).   
 Higher PETCO2 levels during supine assessments were observed in SA participants in 
comparison to CA participants. PETCO2 was correlated with lower CVR (r= -0.32, p=0.048) and 
higher aCBF (r=0.34, p=0.033) in the total study sample. A multiple linear regression analysis 
revealed an interaction effect between ethnic group and PETCO2 in predicting aCBF (adjusted 
R2=0.18; ethnicity*PETCO2 interaction term: β=0.028, p=0.031), suggesting that high PETCO2 in 
SA group explained some of the difference in aCBF between the two groups. 
 Pearson correlation analyses between the central and peripheral arterial properties and 
cerebrovascular hemodynamics during resting supine position revealed several notable 
relationships in each ethnic group (Table 9). In CA group, baPWV was associated with lower 
resting supine MFV (r= -0.74, p<0.001) and greater CVRi (r= 0.75, p<0.001), which were not 
observed in SA group. In addition, baPWV was modestly correlated with reduced cerebrovascular 
reactivity to CO2 under both hypercapnic (r= -0.46, p=0.03) and hypocapnic conditions in CA 
group (r= -0.55, p=0.008); these relationships were not seen in SA group. For SA group, lower 
central artery compliance (CC) and distensibility (DC) were associated with greater 
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cerebrovascular resistance (CC and CVR: r= -0.41, p=0.059 (Figure 6); CC and CVRi: r= -0.57, 
p=0.025; log-transformed DC and CVRi: r= -0.58, p=0.023). No direct relationships between CC 
or DC and aCBF were observed. Although, a strong negative correlation was found between CVR 
and aCBF (r= -0.96, p<0.001), thereby indicating an indirect link between central arterial stiffness 
and brain blood flow in SA group. A similar relationship between CVR and aCBF was observed 
in CA group (r= -0.93, p<0.001), but SA group displayed a greater decline in aCBF with CVR 
(Figure 7). The regression slopes were β= -2.02, p<0.001 for CA group and β= -3.03, p<0.001 for 
SA group. Furthermore, no significant relationship between CC and CVR or DC and CVR was 
observed in CA group.  
 For both groups, CC and log-transformed DC were inversely related to PPcar, and a 
subsequent multiple regression analysis indicated that ethnicity significantly modified these 
association (ethnicity*log-transformed DC interaction term: β= -38.78, p=0.01, adjusted R2=0.59; 
ethnicity*CC interaction term: β= -0.03, p=0.02, adjusted R2=0.53,). Specifically, SA participants 
with less compliant and distensible carotid arteries had significantly higher PPcar compared to CA 
participants (Figure 8 and Figure 9).  
 In both groups, a link between carotid artery IMT and altered cerebral blood flow properties 
was observed, where increased IMT was associated with higher MCA PI during the supine rest 
assessment (Table 9, CA: r=0.46, p=0.032; SA: r=0.83, p<0.001). This relationship differed 
significantly between CA and SA groups; a multiple linear regression analysis revealed that 
ethnicity had a significant effect on the relationship between IMT and PI, where a unit increase in 
IMT was associated with a greater increase in PI in SA group compared to CA group (Figure 10). 
IMT was also associated with a greater RI in SA group (r=0.81, p<0.001, Figure 11); however, 
this was not seen in CA group. Similar relationships were observed between IMT and PI and RI 
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in the seated position in SA group (seated PI: r=0.71, p=0.002; seated RI: r=0.68, p=0.004), but 
these were not seen in CA group (seated PI: r=0.21, p=0.359; seated RI: r=0.10, p=0.669).  
 Additional correlation analyses were performed to explore the relationship between the 
indicators of arterial stiffness (that were statistically significant between the two groups) and 
anthropometric measurements and blood biomarkers in each ethnic group (Table 10). No 
significant relationships were observed in the CA group except for the correlation between baPWV 
and WHR (r=0.44, p=0.04). In SA group, height was correlated with baPWV (r= 0.46, p=0.036), 
whereas BMI (r= -0.44, p=0.05) was inversely related to baPWV. In addition, a positive 
relationship was seen between height and CC in SA group (r= 0.44, p=0.04). No significant 
relationships were detected between the blood markers and indictors of arterial stiffness in either 
ethnic group. 
 Relationships with the performance on cognitive tasks and structural and functional arterial 
properties and cerebrovascular hemodynamics were sought; however, no relevant correlations 
were found. 
 
6.8 Relationships between Physical Activity and Arterial Structure and Function 
and Cerebrovascular Hemodynamic Properties 
 Correlations between SWA-measured physical activity and indices of arterial stiffness, 
arterial structural and functional properties, cerebrovascular variables, and clinically-relevant 
blood markers for each ethnic group are presented in Table 11. In the CA group, lower BMI was 
associated with greater daily AEE (r= -0.43, p=0.045), square root transformed PAEE (r= -0.46, 
p=0.033), and square root transformed duration of physical activity (r= -0.54, p=0.009). Similarly, 
in SA group, negative trends were observed between BMI and duration of physical activity (r= -
0.42, p=0.063) and number of steps per day (r= -0.41, p=0.069). The same SWA variables in SA 
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group were significantly correlated with lower waist circumference (r= -0.56, p=0.01 and r= -0.48, 
p=0.003, respectively). Also, duration of PA and PAEE were associated with lower WHR in SA 
group (r= -0.62, p=0.003 and r= -0.57, p=0.009, respectively), whereas CA group showed a 
positive association between PAEE and WHR (r=0.42, p=0.055). Other unexpected results 
observed in CA group were that TEE, PAEE, and the duration of physical activity were associated 
with greater baPWV (r=0.43, p=0.049; r=0.50, p=0.017; r=0.50, p=0.017, respectively). Likewise, 
in SA group, average daily steps was associated with greater baPWV (r=0.45, p=0.054). No other 
relationships between arterial structural or functional measurements and SWA-measured physical 
activity were observed in the CA group. In SA group, positive linear trends between TEE and log-
transformed DC and CC were observed (DC: r=0.40, p=0.080; CC: r=0.43, p=0.058), but no other 
significant relationships were detected.  
 In both ethnic groups, greater number of daily steps was correlated with greater aCBF (CA: 
r=0.52, p=0.023; SA: r=0.46, p=0.043, Table 11). AEE, PAEE, and duration of physical activity 
were also associated with greater aCBF in CA group (r=0.49, p=0.03; r=0.55, p=0.016; p=0.56, 
p=0.012; p=0.52, p=0.023, respectively); however, these relationships were not detected in the SA 
group. In addition, these variables in CA group were associated with lower MFV (AEE: r= -0.43, 
p=0.044; PAEE: r= -0.49, p=0.019; log-transformed duration of physical activity: r= -0.51, 
p=0.015), and with lower CVR (AEE: r= -0.51, p=0.026; PAEE: r= -0.55, p=0.015; log-
transformed duration of physical activity: r= -0.55, p=0.015). In contrast, no significant 
relationships between SWA-measured physical activity and MFV were observed in SAs. Both 
groups showed a modest association between number of daily steps and lower CVR (CA: r= -0.49, 
p=0.033; SA: r= -0.44, p=0.050). No significant relationship between physical activity and PI was 
observed in either groups. SA group also did not show any relationship with RI. On the other hand, 
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in CA group, a negative association was observed between RI and AEE and daily steps (r= -0.45, 
p=0.038; r= -0.45, p=0.038, respectively). Inverse relationships between SWA-measured physical 
activity variables and cerebrovascular reactivity to CO2 under hypercapnic and hypocapnic 
conditions were observed in CA group. Similarly, trends were observed under hypercapnic 
conditions in SA group, but in contrast to CA group, positive relationships between SWA-
measured physical activity variables and cerebrovascular reactivity to hypocapnic conditions were 
noted in SA group. Relationships between blood markers and SWA data were also examined in 
CA and SA group. SWA-measurements of physical activity were correlated with lower HbAlc 
levels in SA group (TEE: r= -0.47, p=0.028; AEE: r= -0.55, p=0.013; PAEE: r= -0.45 p=0.045; 
duration of physical activity: r= -0.46, p=0.044), and a trend was noted in CA group between 
duration of physical activity and lower HbA1c (r= -0.37, p=0.091). Also, in CA group, greater 
energy expenditure and duration of physical activity were associated with lower CRP levels (AEE: 
r= -0.49, p=0.021; PAEE and duration of physical activity: r= -0.55, p=0.008). A similar trend in 
lower CRP levels was noted in SA group with greater number of steps per day (r= -0.42, p=0.068). 
Lower LDL levels were also correlated with greater energy expenditures in CA group (TEE: r= -
0.60, p=0.003; AEE: r= -0.51, p=0.016; r= -0.51, p=0.017; duration of physical activity: r= -0.46, 
p=0.031), but these relationships were not significant in SA group.  
 
 
 
 
 
 
49 
 
Table 1. Participant Characteristics  
Characteristics CA (n=22) SA (n=22) p-value † 
Demographics  
Age, years 
 
71 ± 5 
 
71 ± 5 
 
--- 
Gender, n M/F 11/11 11/11 --- 
Immigrant, % (n) 27 (6) 100 (22) <0.001 
Body Measurements  
Height, cm 
 
171 ± 10 
 
164 ± 9 
 
0.027 
Weight, kg 79 ± 12 73 ± 13 0.138 
BMI, kg/m2 27 ± 4 27 ± 5 0.922 
Waist Circumference, cm 94 ± 10 104 ± 1 0.006 
Hip Circumference, cm 105 ± 10 108 ± 10 0.367 
WHR α 0.90 ± 0.08 0.96 ± 0.04 0.003 
Body Surface Area, m2 1.90 ± 0.18 1.79 ± 0.17 0.033 
Marital Status  
Married, % (n) 
Divorced, % (n) 
Widowed, % (n) 
 
64 (14) 
27 (6) 
5 (1) 
 
68 (15) 
0 (0) 
32 (7) 
 
1.000 
0.028 
0.051 
Highest Educational Attainment 
Less than High School Edu, % (n) 
High School Edu, % (n) 
Post-Secondary Edu or Higher, % (n) 
Total Years of Education, years 
 
9 (2) 
14 (3) 
77 (17) 
16 ± 4 
 
46 (10) 
27 (6) 
27 (6) 
8 ± 6 
 
0.018 
0.455 
0.003 
<0.001 
Other Health Risk Factors 
Current Smoker, % (n) 
Frequent Alcohol Intake (current), % (n)  
Hypertension, % (n) 
Hyperlipidemia, % (n) 
Diabetes Mellitus, % (n) 
Metabolic Syndrome, % (n) 
Plaque, % (n) 
Arrhythmia, % (n) 
Family History of CVD, % (n) 
Family History of Stroke, % (n) 
Family History of Hypertension % (n) 
 
36 (8) 
91 (20) 
41 (9) 
23 (5) 
0 (0) 
27 (6) 
5 (1) 
18 (4) 
23 (5) 
14 (3) 
27 (6) 
 
0 (0) 
18 (4) 
36 (8) 
41 (9) 
9 (2) 
18 (4) 
36 (8) 
73 (16) 
50 (11) 
27 (6) 
50 (11) 
 
0.006 
<0.001 
1.000 
0.332 
0.469 
0.719 
0.025 
<0.001 
0.117 
0.455 
0.216 
Data are presented as mean ± SD for continuous variables. Categorical variables are presented as 
proportions with the count shown in parentheses. BMI, body mass index; WHR, waist hip ratio; 
Edu, education; CVD, cardiovascular diseases.  
† Significant difference between CA and SA group using two-tailed unpaired t-test for continuous 
variables and z-test for proportions. p ≤ 0.05 was considered statistically significant difference 
(bolded values). 
α Variable failed to meet the assumption of equal variance for parametric statistics; however, the 
outcome of significance was the same when a non-parametric test was applied. For consistency, 
the parametric test results were shown in the table. 
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Table 2. Biochemical Characteristics 
Blood Biomarkers  CA (n=22) SA (n=22) p-value† 
Glucose, mM 
HbA1c, % 
Average Hematocrit, % 
TG, mM 
Total Cholesterol, mM 
HDL, mM 
LDL, mM 
TC/HDL 
CRP, mg/L § 
Glycated Albumin, ng/mL § 
Insulin, μU/mL 
HOMA-IR index, mM/ μU/mL 
5.4 ± 0.5 
5.3 ± 0.4 
42 ± 3* 
1.4 ± 0.8 
5.1 ± 1.1 
1.3 ± 0.3 
3.1 ± 0.9 
3.9 ± 0.9 
2.0 ± 2.2 
--- 
--- 
--- 
5.0 ± 0.7  
5.9 ± 0.6  
43 ± 3 
1.4 ± 0.4 
5.5 ± 1.0 
1.6 ± 0.3  
3.9 ± 1.0  
3.5 ± 0.9 
3.9 ± 5.8 
53 ± 40 
10.8 ± 5.5 
2.4 ± 1.4 
0.031 
<0.001 
0.505 
0.912 
0.198 
0.006 
0.013 
0.128 
0.152 
--- 
--- 
--- 
Data are presented as mean ± SD. HbA1c, glycosylated hemoglobin; TG, triglycerides; HDL, high-
density lipoproteins; LDL, low-density lipoproteins; TC/HDL, total cholesterol to high-density 
lipoprotein ratio; CRP, C-reactive protein; HOMA-IR: homeostasis model assessment of insulin 
resistance. The sample size (n) for each measure was indicated in the table. 
† Two-tailed unpaired t-test comparing CA group and SA group; p ≤ 0.05 was considered 
statistically significant difference (bolded values). 
§ CRP and glycated albumin were natural log transformed.  
* Sample size was n=21. 
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Table 3. Participant Medications 
Characteristics CA (n=22) SA (n=22) p-value † 
Medications 
Antihypertensive, % (n) 
ACEi, % (n) 
ARB, % (n) 
CCB, % (n) 
Beta-blocker, % (n) 
ASA, % (n)  
Antithrombotic, % (n) 
Statin, % (n) 
Anti-diabetic, % (n) 
Supplements 
Calcium, % (n) 
Vitamin D, % (n) 
 
41 (9) 
14 (3) 
18 (4) 
5 (1) 
5 (1) 
18 (4) 
14 (3) 
32 (7) 
0 (0) 
 
46 (10) 
59 (13) 
 
41 (9) 
9 (2) 
9 (2) 
23 (5) 
18 (4) 
23 (5) 
18 (4) 
  46 (10) 
9 (2) 
 
27 (6) 
23 (5) 
 
1.000 
1.000 
0.660 
0.188 
0.342 
1.000 
1.000 
0.536 
0.469 
 
0.347 
0.032 
Data are presented as proportions with the count shown in parentheses. ACEi, angiotensin 
converting enzyme inhibitor; ARB, angiotensin II receptor blocker; CCB, calcium channel 
blocker; ASA, acetylsalicylic acid. 
† z-test comparing proportions between CA group and SA group; p ≤ 0.05 was considered 
statistically significant difference (bolded value). 
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Table 4. Qualitative and Quantitative Measures of Physical Activity 
Physical Activity CA (n=18) SA (n=22) p-value† 
Self-Reported 
Inactive Lifestyle, % (n) 
Active Lifestyle, % (n) 
Highly Active Lifestyle, % (n) 
 
0 (0) 
33 (6) 
67 (12) 
 
59 (13) 
36 (8) 
5 (1) 
 
<0.001 
0.894 
<0.001 
 CA (n=22) SA (n=20)  
SenseWearTM Armband-
Measurements  
Daily METs 
TEE, kcal/day 
AEE, kcal/day 
PAEE, kcal/day § 
Duration of PA, hour/day § 
Steps, count/day 
 
 
1.3 ± 0.2 
2324 ± 398 
553 ± 271 
359 ± 231 
1.3 ± 0.8 
8095 ± 2719 
 
 
1.3 ± 0.3 
2106 ± 430 
498 ± 351 
300 ± 354 
1.3 ± 1.3 
5623 ± 2730 
 
 
0.854 
0.096 
0.574 
0.282 
0.538 
0.006 
 
Data are presented as mean ± SD for continuous variables. Categorical variables are presented as 
proportions with the count shown in parentheses. METs, metabolic equivalent units; TEE, total 
energy expenditure; AEE, activity-related energy expenditure; PAEE, physical activity-related 
energy expenditure; PA, physical activity. 
† Statistical significance from CA using two-tailed unpaired t-test for continuous variables and z-
test for proportions. p ≤ 0.05 was considered statistically significant difference (bolded values), 
and a statistical trend towards significance was defined by 0.05 ≤ p ≤ 0.10. 
§ Duration of daily PA and PAEE were square root transformed. 
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Table 5. Participant Performance on Simple and Choice Reaction Time Cognitive Tasks 
Reaction Time Tasks CA (n=18) SA (n=22) p-value† 
Log10 Right Simple RT, ms α 
CV log10 Right Simple RT, % 
Log10 Left Simple RT, ms α 
CV log10 Left Simple RT, % 
Log10 Right Choice RT, ms 
CV log10 Right Choice RT, % 
Log10 Left Choice RT, ms 
CV log10 Left Choice RT, % 
2.45 ± 0.04 
0.02 ± 0.01 
2.47 ± 0.06 
0.01 ± 0.01 
2.70 ± 0.06 
0.012 ± 0.006 
2.71 ± 0.05 
0.011 ± 0.005 
2.69 ± 0.15 
0.02 ± 0.01 
2.69 ± 0.16 
0.02 ± 0.01 
2.82 ± 0.09 
0.013 ± 0.008 
2.81 ± 0.10 
0.021 ± 0.046 
<0.001 
0.815 
<0.001 
0.555 
<0.001 
0.846 
<0.001 
0.293 
Data are presented as log transformed mean ± SD. Transformation was made to normalize the data. 
RT, reaction time; ms, milliseconds; CV, coefficient of variance.  
† Two-tailed unpaired t-test comparing CA group and SA group; p ≤ 0.05 was considered 
statistically significant difference (bolded values). 
α Variables failed to meet the assumption of equal variance for parametric statistics; however, non-
parametric statistics gave the same p-value. For consistency, the parametric test results were shown 
in the table. 
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Table 6. Measurements of Arterial Structure and Function and Cerebral Blood Flow in the  
               Supine Rest Position 
Measurements CA SA p-value† 
Arterial Structure and Function    
PPcar, mmHg α 
baPWV, m/s 
Mean IMT, mm 
Maximum IMT, mm α 
DC, 10-3/kPa § 
CC, mm2/MPa 
46 ± 10*** 
11 ± 2 
0.74 ± 0.14 
0.85 ± 0.17 
29 ± 16*** 
789 ± 323*** 
59 ± 18 
12 ± 2*** 
0.68 ± 0.09 
0.68 ± 0.07 
22 ± 11 
601 ± 282 
0.005 
0.080 
0.073 
<0.001 
0.109 
0.048 
ICA Diameter and Velocity 
Right ICA  
Diameter, cm § 
MFV, cm/s § 
 
 
0.53 ± 0.12** 
22 ± 7** 
 
 
0.52 ± 0.09 
27 ± 9 
 
 
0.913 
0.046 
Left ICA  
Diameter, cm § 
MFV, cm/s  
 
0.50 ± 0.08*** 
23 ± 6** 
 
0.50 ± 0.08 
26 ± 6 
 
0.803 
0.140 
Supine CBF 
Right ICA, mL/min § 
Left ICA, mL/min § 
Anterior, mL/min § 
 
268 ± 76** 
265 ± 91** 
536 ± 134* 
 
349 ± 153 
311 ± 130 
660 ± 233 
 
0.062 
0.204 
0.065 
Data are presented as mean ± SD. baPWV, brachial-ankle pulse wave velocity; PPcar, carotid pulse 
pressure; IMT, intima-media thickness; DC, distensibility coefficient; CC, compliance coefficient; 
ICA, internal carotid artery; MFV, mean flow velocity. The sample size (n) for each measure was 
indicated in the table. Anterior CBF refers to the sum of the right and left ICA blood flow. 
† Two-tailed unpaired t-test comparing CA group and SA group; p ≤ 0.05 was considered 
statistically significant difference (bolded values), and a statistical trend towards significance was 
defined by 0.05 ≤ p ≤ 0.10. 
α Variables failed to meet the assumption of equal variance for parametric statistics; however, the 
outcome of significance was the same when a non-parametric test was applied. For consistency, 
the results of the parametric test were presented in the table. 
§ DC, right ICA diameter, right ICA MFV, right ICA CBF, left ICA diameter, left ICA CBF, and 
anterior CBF were natural log transformed. 
* Sample size was n=19, ** n=20, and *** n=21. 
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Table 7. Cerebrovascular and Cardiovascular Variables in Supine and Seated Rest  
                  Positions 
Data are presented as mean + SD. SFV, systolic flow velocity; DFV, diastolic flow velocity; MFV, 
mean flow velocity; CVR, cerebrovascular resistance (MAP/aCBF); CVRi, cerebrovascular 
resistance index (MAP/MFV); RI, resistive index; PI, pulsatility index; HR, heart rate; bpm, beats 
per minute; SBP, systolic blood pressure; DBP, diastolic blood pressure; MAP, mean arterial 
pressure; TPR, total peripheral resistance; Qi, cardiac index; PETCO2, end-tidal carbon dioxide. 
The sample size (n) for the measurements were indicated in the table. 
† Two-tailed unpaired t-test comparing SA group and CA group. p ≤ 0.05 was considered 
statistically significant difference (bolded values), and 0.05 ≤ p ≤ 0.10 was considered as statistical 
trends towards significance.  
* Sample size was n=19 and ** n=21.
 Supine Seated 
TCD Measurements 
CA  
(n=22) 
SA  
(n=15) 
p-
value† 
CA  
(n=22) 
SA  
(n=16) 
p-
value† 
SFV, cm/s 
DFV, cm/s 
MFV, cm/s 
CVR, mmHg/mL/min 
CVRi, mmHg/cm/s 
RI 
PI 
79 ± 18 
34 ± 8 
53 ± 12 
0.19 ± 0.05*  
1.87 ± 0.51 
0.58 ± 0.08 
0.83 ± 0.13 
93 ± 26  
39 ± 15 
61 ± 19 
0.16 ± 0.05 
1.64 ± 0.43 
0.59 ± 0.06 
0.91 ± 0.16  
0.063 
0.259 
0.145 
0.063 
0.161 
0.654 
0.085 
76 ± 17 
31 ± 7 
50 ± 11 
0.19 ± 0.06* 
1.38 ± 0.43 
0.61 ± 0.11 
0.92 ± 0.15 
91 ± 22  
35 ± 11 
57 ± 15  
0.16 ± 0.05 
1.29 ± 0.35 
0.62 ± 0.06 
1.00 ± 0.16 
0.030 
0.286 
0.091 
0.075 
0.520 
0.656 
0.107 
Cardiovascular 
Variables 
CA  
(n=22) 
SA  
(n=22) 
 CA  
(n=22) 
SA  
(n=22) 
 
HR, bpm 
SBP, mmHg 
DBP, mmHg 
MAP, mmHg 
TPR, mmHg/L/min 
Qi, L/min/m2 
PETCO2, mmHg 
64 ± 10 
133 ± 11 
74 ± 7 
94 ± 8 
18 ± 5** 
3.0 ± 0.8** 
37 ± 3 
67 ± 10 
139 ± 18 
68 ± 9 
94 ± 11 
15 ± 5  
3.8 ± 0.8 
41 ± 3** 
0.336 
0.226 
0.017 
0.981 
0.035 
0.003 
<0.001 
64 ± 9 
134 ± 13 
73 ± 10 
94 ± 11 
19 ± 7** 
3.0 ± 0.8** 
36 ± 4 
66 ± 12 
138 ± 20 
69 ± 10 
94 ± 14 
17 ± 5 
3.4 ± 0.7 
40 ± 4** 
0.516 
0.524 
0.205 
0.968 
0.264 
0.093 
0.005 
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Table 8. Cerebrovascular Reactivity to Carbon Dioxide under Hypercapnic and Hypocapnic  
               Conditions 
Cerebrovascular Reactivity CA (n=22) SA (n=16) p-value† 
HICO2, Δcm/s/ΔmmHg § 
LOWCO2, Δcm/s/ΔmmHg 
HICO2, %/ΔmmHg § 
LOWCO2, %/ΔmmHg 
1.8 ± 0.7 
1.5 ± 0.5 
3.6 ± 1.2 
4.1 ± 1.5 
2.4 ± 1.8 
1.4 ± 0.8 
4.1 ± 2.4 
3.2 ± 1.7  
0.330 
0.466 
0.658 
0.096 
Data are presented as mean ± SD. HICO2, hypercapnia; LOWCO2, hypocapnia. 
† Two-tailed unpaired t-test comparing SA group and CA group; p ≤ 0.05 was considered 
statistically significant difference, and 0.05 ≤ p ≤ 0.10 was considered as statistical trends towards 
significance. 
§
 Absolute (Δcm/s/ΔmmHg) and relative (%/ΔmmHg) HICO2 cerebrovascular reactivity were 
natural log transformed. 
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Figure 2. Cardiovascular and Cerebrovascular Responses to Hypocapnia and Hypercapnia  
                 in White Caucasian and South Asian Older Adults 
Absolute (delta) change from I: baseline to hypocapnia and II: baseline to hypercapnia. Open bars 
represented CA group and closed bars represented SA group. * indicates significant difference 
between groups at p < 0.05. 
 
* 
* 
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Figure 3. Age-Associated Increase in Arterial Stiffness in CA and SA Older Adults 
Brachial-ankle pulse wave velocity (baPWV) was plotted against age in CA group (○) and SA 
group (●). ▲ represents participants in SA group who were identified during the study to have 
untreated hypertension or signs of ipsilateral ICA stenosis. Age-related increase in baPWV was 
observed in CA group (r=0.47, p=0.029, n=22) and SA group (r=0.44, p=0.045, n=21). The middle 
dashed line represented the relationship for the total sample (r=0.43, p=0.004). Ethnicity did not 
have a significant effect on this relationship (adjusted R2=0.20, β=0.05, p=0.654). 
SA 
Total 
CA 
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Figure 4. Relationship between Age and Anterior Cerebral Blood Flow in SA and CA Older  
                 Adults 
Log-transformed anterior cerebral blood flow (aCBF) was plotted against age in CA group (○), 
SA group (●). ▲ represents participants in SA group who were identified during the study to have 
untreated hypertension or signs of ipsilateral ICA stenosis. A linear trend was noted in the total 
study sample (dashed line: r= -0.26, p=0.098), but no relationship found when ethnic groups were 
analyzed separately (CA: r= -0.12, p=0.626, n=19; SA: r= -0.34, p=0.118, n=22). 
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Figure 5. Relationship between Arterial Stiffness and Anterior Cerebral Blood Flow in CA  
                 and SA Older Adults 
Log-transformed anterior cerebral blood flow (aCBF) was plotted against brachial-ankle pulse 
wave velocity (baPWV) in CA group (○) and SA group (●). ▲ represents participants in SA group 
who were identified during the study to have untreated hypertension or signs of ipsilateral ICA 
stenosis. Middle dashed line represented the total study sample. No significant relationship was 
found in either ethnic group. Ethnicity had no effect on this relationship (adjusted R2=0.10, β= -
0.02, p= 0.433).  
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Table 9. Correlations between Arterial Structure and Function and Cerebrovascular  
                  Properties in CA and SA Older Adults 
 CA SA 
 baPWV PPcar DC § CC IMT baPWV PPcar DC § CC IMT 
aCBF § 0.40 0.23 -0.09 -0.26 -0.30 0.20 0.07 0.18 0.31 -0.25 
MFV -0.74** 0.14 0.11 0.04 0.28 -0.04 0.05 0.28 0.30 -0.42 
CVRi 0.75** -0.10 -0.17 -0.21 -0.25 0.21 0.28 -0.58* -0.57* 0.39 
CVR -0.33 -0.20 0.07 0.13 0.37 -0.09 0.11 -0.30 -0.41* 0.30 
PI 0.33 0.057 0.01 0.07 0.46* 0.14 0.22 -0.20 -0.22 0.83** 
RI 0.21 0.28 -0.04 0.11 -0.07 0.12 0.15 -0.13 -0.17 0.81** 
HICO2, 
Δcm/s/mmHg § 
-0.46* 0.07 0.15 0.09 0.35 -0.37 -0.10 0.18 0.15 -0.04 
LOCO2,  
Δcm/s/mmHg 
-0.55* -0.07 0.15 0.09 0.20 -0.03 0.21 -0.21 -0.25 0.24 
Data are presented as the Pearson product coefficient. baPWV, brachial-ankle pulse wave velocity; 
PPcar, carotid pulse pressure; DC, distensibility coefficient; CC, compliance coefficient; IMT, 
intima-media thickness; aCBF, anterior cerebral blood flow; MFV, mean flow velocity; CVRi, 
cerebrovascular resistance index (MAP/MFV); CVR, cerebrovascular resistance (MAP/aCBF); PI, 
pulsatility index; RI, resistive index; HICO2, cerebrovascular reactivity to hypercapnia; LOWCO2, 
cerebrovascular reactivity to hypocapnia. 
* p < 0.05 and ** p < 0.001 were considered statistically significant. 
§ DC, aCBF and HICO2 were natural log transformed. 
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Figure 6. Relationship between Carotid Artery Compliance and Cerebrovascular Resistance  
                 in SA Older Adults 
Cerebrovascular resistance (CVR=MAP/aCBF) was plotted against carotid compliance coefficient 
in SA group (●). ▲ represents participants in SA group who were identified during the study to 
have untreated hypertension or signs of ipsilateral ICA stenosis. A significant relationship was 
found in SA group (r= -0.41, p=0.059, n=22). 
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Figure 7. Relationship between Cerebral Blood Flow and Cerebrovascular Resistance in SA  
                Older Adults 
Cerebral blood flow (aCBF) was plotted against cerebrovascular resistance (CVR=MAP/aCBF) in 
CA group (○) and SA group (●). ▲ represents participants in SA group who were identified during 
the study to have untreated hypertension or signs of ipsilateral ICA stenosis. A significant 
relationship was found in CA group (r= -0.93, p<0.001, n=19) and SA group (r= -0.96, p<0.001, 
n=22). Ethnicity had a significant effect on this relationship (adjusted R2=0.90, β= -1.00, p<0.001). 
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Figure 8. Relationship between Carotid Artery Distensibility and Pulse Pressure in CA and  
                 SA Older Adults 
Carotid artery pulse pressure, PPcar, was plotted against log-transformed carotid distensibility 
coefficient in CA group (○) and SA group (●). ▲ represents participants in SA group who were 
identified during the study to have untreated hypertension or signs of ipsilateral ICA stenosis. A 
significant relationship was found in CA group (r= -0.61, p=0.004, n=21) and SA group (r= -0.77, 
p<0.001, n=22). Ethnicity had a significant effect on this relationship (adjusted R2=0.59, β= -38.8, 
p=0.01).  
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Figure 9. Relationship between Carotid Artery Compliance and Pulse Pressure in CA and  
                 SA Older Adults 
Carotid artery pulse pressure, PPcar, was plotted against carotid compliance coefficient in CA group 
(○) and SA group (●). ▲ represents participants in SA group who were identified during the study 
to have untreated hypertension or signs of ipsilateral ICA stenosis. A significant relationship was 
found in CA group (r= -0.56, p=0.009, n=21) and SA group (r= -0.72, p<0.001, n=22). Ethnicity 
had a significant effect on this relationship (adjusted R2=0.53, β= -0.03, p=0.02).  
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Figure 10. Relationship between Common Carotid Artery Intima-Media Thickness and  
                    Middle Cerebral Artery Pulsatility Index in CA and SA Older Adults 
Carotid artery intima-media thickness, IMT, was plotted against pulsatility index (in supine), PI, 
at the middle cerebral artery in CA group (○) and SA group (●). ▲ represents participants in SA 
group who were identified during the study to have untreated hypertension or signs of ipsilateral 
ICA stenosis. A significant relationship was found in CA group (r=0.46, p=0.032, n=22) and SA 
group (r=0.83, p<0.001, n=15). Ethnicity had a significant effect on this relationship (adjusted 
R2=0.45, β=0.92, p=0.009).  
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Figure 11. Relationship between Common Carotid Artery Intima-Media Thickness and  
                    Middle Cerebral Artery Resistive Index in CA and SA Older Adults 
Carotid artery intima-media thickness, IMT, was plotted against resistive index (in supine), RI, at 
the middle cerebral artery in CA group (○) and SA group (●). ▲ represents participants in SA 
group who were identified during the study to have untreated hypertension or signs of ipsilateral 
ICA stenosis. A significant relationship was found in SA group (r=0.81, p<0.001, n=15) but not in 
CA group (r= -0.07, p=0.76, n=22). Ethnicity had a significant effect on this relationship (adjusted 
R2=0.11, β=0.54, p=0.017).  
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Table 10. Correlations between Arterial Stiffness, Anthropometric Measurements and Blood  
                 Biomarkers in CA and SA Older Adults  
 CA SA 
 baPWV PPcar CC baPWV PPcar CC 
Anthropometric  
   Measurements 
Height 0.35 0.15 0.184 0.46* -0.21 0.44* 
BMI -0.25 -0.139 0.09 -0.44* -0.25 0.16 
Waist 0.26 -0.004 -0.10 -0.37 -0.16 0.05 
WHR 0.44* 0.001 -0.27 0.02 0.07 -0.15 
                 Blood  
       Biomarkers 
Glucose -0.16 -0.08 0.14 0.012 -0.16 -0.01 
HbA1c -0.06 0.10 -0.24 -0.15 0.22 -0.24 
CRP § -0.22 0.05 -0.37 0.17 0.14 -0.06 
TCHOL -0.29 -0.01 -0.16 -0.18 0.16 0.03 
HDL -0.14 -0.03 0.02 0.06 -0.10 0.12 
LDL -0.33 -0.04 -0.08 -0.18 0.18 -0.01 
TC/HDL -0.04 0.13 -0.21 0.26 -0.07 -0.10 
TG 0.08 0.11 -0.32 0.05 -0.13 0.07 
G-Alb § --- --- --- -0.14 0.13 -0.15 
Insulin --- --- --- -0.18 -0.33 0.35 
HOMA-IR --- --- --- -0.17 -0.34 0.34 
Data are presented as the Pearson product coefficient. baPWV, brachial-ankle pulse wave velocity; 
PPcar, carotid pulse pressure; CC, compliance coefficient; WHR, waist to hip ratio; HbA1c, 
glycosylated hemoglobin; CRP, C-reactive protein; TCHOL, total cholesterol; HDL, high-density 
lipoprotein; LDL, low-density lipoprotein; TC/HDL, total cholesterol to high-density lipoprotein 
ratio; TG, triglycerides; G-Alb, glycated albumin; HOMA-IR, homeostasis model assessment of 
insulin resistance. 
§ CRP and G-Alb were natural log transformed.  
* p ≤ 0.05 was considered statistically significant.
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Table 11. Pearson Correlations between Quantitative Measures of Physical Activity, Arterial  
                 Structure and Function, Cerebrovascular Hemodynamic Properties, and Blood  
                 Biomarkers in CA and SA Older Adults 
 CA SA 
 Daily Energy Expenditure 
Duration 
of PA‡ 
 
Daily 
Steps 
Daily Energy Expenditure 
Duration 
of PA‡ 
 
 TEE AEE PAEE‡ TEE AEE PAEE‡ 
Daily 
Steps 
Anthropometric 
Measurements 
 
BMI -0.13 -0.43* -0.46* -0.54* -0.23 0.25 0.01 -0.29 -0.42# -0.41# 
Waist 
Circumference 
0.37# -0.10 0.002 -0.12 -0.17 0.14 -0.08 -0.43# -0.56* -0.48* 
WHR 0.46* 0.29 0.42* 0.36# 0.24 -0.19 -0.25 -0.57* -0.62* -0.24 
Arterial Structure 
and Function 
 
baPWV 0.43* 0.38# 0.50* 0.50* 0.20 0.024 0.04 0.20 0.21 0.45* 
PPcar 0.06 0.05 0.02 0.03 -0.08 -0.34 -0.15 -0.16 -0.08 -0.01 
DC 0.11 0.04 0.05 -0.003 0.12 0.40# 0.26 0.25 0.17 0.05 
CC 0.12 0.04 0.02 -0.02 -0.08 0.43# 0.21 0.31 0.21 0.09 
IMT -0.19 -0.01 -0.10 -0.10 -0.03 0.14 0.13 0.10 0.04 0.05 
Cerebrovascular 
Variables 
 
aCBF § 0.35 0.49* 0.55* 0.56* 0.52* 0.19 0.09 0.23 0.18 0.46* 
MFV -0.43* -0.43* -0.49* -0.51* -0.31 0.18 0.18 0.06 0.06 0.48# 
CVR -0.43# -0.51* -0.55* -0.55* -0.49* -0.28 -0.18 -0.34 -0.29 -0.44 
PI -0.01 0.04 0.18 0.14 -0.21 0.04 0.20 0.12 0.10 -0.26 
RI -0.15 -0.45* -0.33 -0.38# -0.45* 0.09 0.27 0.19 0.18 -0.29 
HICO2, 
Δcm/s/mmHg § 
-0.28 -0.35 -0.39# -0.44* -0.14 0.08 0.04 -0.46# -0.48# -0.15 
LOWCO2, 
Δcm/s/mmHg 
-0.35 -0.42* -0.47* -0.53* -0.33 0.57* 0.68* 0.67* 0.66* 0.278 
Blood Markers  
HbA1c -0.12 -0.27 -0.32 -0.37# -0.12 -0.47* -0.55* -0.45* -0.46* -0.21 
CRP § -0.37# -0.49* -0.55* -0.55* -0.12 -0.06 0.11 -0.02 -0.04 -0.42# 
LDL -0.60* -0.51* -0.51* -0.46* -0.21 0.13 0.23 0.09 0.09 -0.21 
Data are presented as the Pearson product coefficient. TEE, total energy expenditure; AEE, activity-
related energy expenditure; PAEE, physical activity-related energy expenditure; PA, physical activity; 
baPWV, brachial-ankle pulse wave velocity; PPcar, carotid pulse pressure; DC, distensibility coefficient; 
CC, compliance coefficient; IMT, intima-media thickness; BMI, body mass index; WHR, waist to hip ratio; 
aCBF, anterior cerebral blood flow; MFV, mean flow velocity; CVR, cerebrovascular resistance 
(MAP/aCBF); PI, pulsatility index; RI, resistive index; HICO2, cerebrovascular reactivity to hypercapnia; 
LOWCO2, cerebrovascular reactivity to hypocapnia; HbA1c, glycosylated hemoglobin; CRP, C-reactive 
protein; LDL, low-density lipoprotein. 
* p < 0.05 and ** p < 0.001 were considered statistically significant; # 0.05 ≤ p ≤ 0.10 was considered as 
statistical trends towards significance. 
‡ PAEE and duration of PA were square root transformed. 
§ aCBF, HICO2 and CRP were natural log transformed.
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7 Discussion 
The primary objectives of the present study were to investigate ethnic differences in:  
i) structural and functional vascular properties and cerebral hemodynamics and ii) the relationship 
between arterial stiffness and resting cerebral blood flow (aCBF) in CA and SA older adults. 
Specifically, the ethnic groups were compared for differences in baPWV, carotid artery pulse 
pressure (PPcar), distensibility, compliance, and wall thickness (IMT) as well as aCBF, 
cerebrovascular resistance (CVR) and cerebrovascular reactivity to CO2. The first hypothesis that 
SA older adults had greater arterial stiffness compared to age- and gender-matched CAs was 
confirmed by the findings that SAs tended to have faster baPWV, reduced carotid arterial 
compliance, and higher pulse pressure. A difference in arterial structure was also observed between 
CAs and SAs, where SAs displayed a trend for less IMT compared to CAs. Contrary to the second 
hypothesis, SAs appeared to have trends for greater aCBF compared to CAs. Furthermore, a trend 
was observed for lower CVR in SAs compared to CAs, whereas cerebral blood flow velocity 
(MFV), RI and PI were comparable between the two groups. Contrary to the third hypothesis, 
cerebrovascular reactivity to CO2 was not different between CAs and SAs. Finally, the fourth 
hypothesis that increased arterial stiffness in SAs would be associated with a reduction in aCBF 
was confirmed by the finding that reduced central arterial compliance, an indicator of regionally-
specific arterial stiffness, was associated with greater CVR, and this was in turn associated with a 
greater reduction in aCBF.  
The secondary objectives of this study were to examine: i) the relationship between 
structural and functional vascular properties and cerebral hemodynamics in each ethnic group; ii) 
ethnic differences in health factors, including blood biomarkers and physical activity; and iii) 
ethnic differences in cognitive function, along with exploring the relationship between central 
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arterial and cerebrovascular health and cognitive performance. The study findings suggest that 
carotid artery wall thickness (IMT) was associated with greater increase in MCA PI and RI in SAs 
in comparison to CAs. Results from fasting blood samples revealed that SAs had higher HbA1c, 
HDL, and LDL levels, but lower fasting glucose levels compared to CAs. Furthermore, the amount 
of free-living physical activity, estimated by the number of daily steps, was less in SAs compared 
to CAs. Of note, additional correlation analyses revealed that greater physical activity in both 
ethnic groups demonstrated beneficial effects on aCBF and lowering blood biomarkers associated 
with the risk of cardiovascular diseases, including HBA1c, CRP and LDL. Finally, SA older adults 
performed slower on the cognitive tasks than CAs, but no meaningful relationships were observed 
between cognitive performance and structural and functional vascular properties or 
cerebrovascular hemodynamics. 
 
7.1 Ethnic Disparities in Arterial Stiffness and Arterial Structure and Function 
7.1.1 Arterial Stiffness and Arterial Function 
In the present study, baPWV was examined as a surrogate for central arterial stiffness along 
with regionally-specific central artery stiffness indicators of carotid artery pulse pressure, 
distensibility, and compliance in CA and SA older adults. Consistent with previous studies (Din et 
al., 2006; Gunarathne et al., 2009; Webb et al., 2012) the present study confirmed that SAs had 
increased central arterial stiffness compared to age- and gender-matched CAs. It was observed that 
baPWV tended to be higher in SAs compared to CAs (p=0.08). Furthermore, this study observed 
for the first time in a SA population that carotid artery compliance was lower and pulse pressure 
was greater compared to CAs (Table 6). Taken together, these findings suggest increased arterial 
stiffness in SAs. Increased central arterial stiffness is a well-established predictor of cardio- and 
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cerebrovascular morbidity and mortality independent of other risk factors (Sutton-Tyrrell et al., 
2005; Mattace-Raso et al., 2006; Vlachopoulos et al., 2012; Gepner et al., 2014). Excess mortality 
from these diseases among SAs is well documented (Balarajan et al. 1984; Balarajan 1991; Wild 
& Mckeigue 1997; Gunarathne et al., 2009); however, the role of arterial stiffness in these diseases 
has not been thoroughly examined in this population.  
Low arterial compliance and greater central pulse pressure observed in SAs are 
characteristic of stiff arteries. The common carotid arteries have elastic (compliant) properties and 
are involved in dissipating the pressure waves generated by each heartbeat and transforming the 
pulsatile characteristics of flow to steady peripheral flow. The central arteries are the first line of 
defense to minimize large changes in pressure to extend in the microcirculation of peripheral 
organs and tissues, such as the brain. Compliance is defined as the change in volume per unit 
change in pressure (ΔV/ΔP). For a given change in blood volume, the change in pressure (pulse 
pressure) is determined by arterial compliance. Normal compliant arteries are able to expand 
during systole and recoil during diastole and accommodate large volume of blood with little effect 
on the blood pressure. On the other hand, in less compliant (stiff) arteries, the ability to expand 
and recoil is greatly reduced, and as a consequence, this results in greater pulse pressure for a given 
change in volume. In this study, less compliant (and distensible) arteries in SAs was associated 
with a greater increase in pulse pressure compared to CAs (Figure 8 & 9). It seems logical that 
greater pulse pressures is a consequence of less compliant arteries, but due to the experimental 
design of the study, a cause and effect relationship between central pulse pressures and compliance 
cannot be established. Theoretically, with advancing age central arteries are exposed to a lifetime 
of pressure that can lead to fatigue and breakdown of the vessel’s structure. When the structural 
composition of the central arteries become compromised, the vessels’ ability to cushion the 
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pressure waves is diminished and the arteries become stiffer. As a consequence, the pulse wave 
transit time is smaller, and therefore, the reflected waves travel to and from the reflection points 
sooner, thereby augmenting the systolic phase and reducing the diastolic phase of the pressure 
waveform (O’Rouke et al., 2010) (Figure 1). The stiffening of arteries and faster pulse waves are 
responsible for larger central pulse pressures. Over time, these pulse pressures accelerate arterial 
damage and reduce arterial function even further; thus, this process becomes a vicious cycle of 
vessel wall degradation. Elevated central pulse pressures associated with arterial stiffness can 
extend into the brain and cause irreversible structural changes and microvascular damage 
(Henskens et al., 2008; Aribisala et al., 2014). Increased arterial stiffness is associated with silent 
cerebral infarcts and white matter hyperintensities (Saji et al., 2011; Saji et al., 2012; Poels et al., 
2012; Tsao et al., 2013). The results from this study indicate that asymptomatic SA older adults 
display greater central arterial stiffness that is associated with greater resistance to brain blood 
flow. This information provides insight into the mechanisms that might contribute to the 
pathogenesis of cerebrovascular diseases and could, in part, explain the higher prevalence of such 
diseases in SA communities. These findings should be strengthened by additional studies that 
explore the relationship between arterial stiffness and brain lesions in SA communities. 
Pulse pressure is the difference between systolic (SBP) and diastolic blood pressures 
(DBP). High pulse pressures result from elevated SBP and/or a reduction in DBP. The SA older 
adults in this study had similar SBP values as the CA older adults, but the SAs had significantly 
lower DBP values during the supine assessment, resulting in widened pulse pressures (Table 7). 
This observation is consistent with other studies that have reported low DBP values in the SA 
populations compared with CA populations (Lyratzopoulos et al., 2005; McElduff et al., 2005). 
Some studies have observed the opposite (Williams, 1993; Cappuccio et al., 1997); however, these 
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studies examined young SAs, and therefore, it is difficult to directly compare their BP values with 
that of the SA older adults in the present study. With advancing age, DBP rises until 50 years of 
age, after which it levels off or declines in all ethnic groups (including SAs) (Landahl & Bengtsson, 
1986; Burt et al., 1995; Franklin et al., 1997; Hakala & Tilvis, 1998; McElduff et al., 2005). Low 
DBP values in SA older adults observed in this study could be a consequence of greater arterial 
stiffness (less compliant arteries and greater baPWV). A low DBP is reportedly associated with 
greater risk of ischemic stroke and white matter lesions (Reshef et al., 2011). High pulse pressure 
signifies that greater volume of blood has gone through the central vessels to the periphery during 
systole and insufficient flow during diastole, which renders the brain vulnerable to ischemic events 
during diastolic phase. Low DBP among SA older adults in this study indicates that they may be 
at high risk for cerebrovascular ischemic events compared to CA older adults; this calls for further 
work with larger sample size studies to confirm this speculation. 
7.1.2 Potential Explanations for Elevated Arterial Stiffness in South Asians  
Age-related changes in vascular structure and function increase arterial stiffness (Nichols 
et al., 2011). In the present study, age was associated with increased arterial stiffness (baPWV) in 
both CAs and SAs (Figure 2). Although there was a significant difference in arterial stiffness 
between the two ethnic groups, the age-related increase in arterial stiffness appeared to be similar. 
It can be postulated that changes in arterial stiffness in old age may be similar between CAs and 
SAs, but it remains uncertain whether ethnic differences exist in the progression of arterial stiffness 
with aging during the early years of life. Moreover, the potential mechanisms underlying increased 
arterial stiffness in the SA population are still unclear. Oxidative stress (Wang et al., 2012), 
inflammation (Yasmin et al., 2004; Vlachopoulos et al., 2005), and reduced nitric oxide 
bioavailability (Kinlay et al., 2001; Wilkinson, 2002) are associated with increased arterial 
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stiffness and have been studied in SAs, (Murphy et al., 2007; Dotesenko et al., 2007), but whether 
these are related to arterial stiffness in SAs remains elusive. Also, elevated arterial stiffness has 
been reported with certain chronic diseases (cardio- and cerebrovascular diseases, end-stage renal 
disease) (London et al., 1990; Giannattasio et al., 2004; Meguro et al., 2009; De Silva et al., 2009) 
as well as cardiometabolic risk factors, including diabetes (Salomaa et al., 1995; Schram et al., 
2002; Schram et al., 2004), hypertension (Benetos, 2002), hyperlipidemia (Wilkinson et al., 2002), 
and obesity (Zebekakis, PE et al., 1846; Toto-Moukouo et al., 1986). SAs in the present study had 
no clinically overt signs of chronic diseases. Two SA participants were diabetic, and the prevalence 
of hypertension and hyperlipidemia were similar across the two ethnic groups, implying that these 
conditions may not explain the increased arterial stiffness in SAs in this study. In fact, correlation 
analyses revealed no significant relationships between the blood markers of glycemic control and 
arterial stiffness in SAs (Table 10). However, considering the small sample size of this study, 
caution must be taken when interpreting these results and speculations.  
Some studies suggests that the presence of diabetes and/or hypertension in SA populations 
is associated with increased arterial stiffness and can explain the higher risk for cardio- and 
cerebrovascular diseases and mortality (McKeigue et al., 1993; Wilkinson et al., 1996; Wild & 
Mckeigue, 1997; Gunarathne et al., 2008b, 2009b). In the current study, when the two SA 
participants with diabetes were removed from the analyses, differences in arterial stiffness between 
CAs and SAs and the relationship between decreased arterial compliance and CVR in SAs 
remained significant at the same or similar strength. This information implies that the presence of 
diabetes does not necessarily account for the ethnic differences in arterial stiffness between CAs 
and SAs. Indeed, high prevalence of diabetes in SAs is well documented in the literature, and 
diabetes can further augment arterial stiffness (Aoun & Blacher, 2001; Schram et al., 2002); 
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however, it did not explain elevated arterial stiffness among SAs in the present study. Furthermore, 
apart from aging, hypertension is a major factor associated with accelerated arterial stiffness and 
risk of stroke (Shekelle et al., 1974; Antikainen et al., 1998). The World Health Organization has 
identified hypertension as one of the leading and preventable causes of premature death worldwide 
(Organization, 2012). In an Ontario survey from 2008, the prevalence of hypertension was highest 
among SAs (Leenen et al., 2008), and similar findings have been reported in other countries 
(Primatesta et al., 2000; Agyemang et al., 2005). Moreover, hypertension contributes to high 
incidence of stroke in the SA population (Cappuccio et al., 1997; Banerjee et al., 2001; 
Bhattacharya et al., 2005). A number of studies reported that hypertension was the most common 
factor in SA ischemic stroke patients (Banerjee et al., 2001; Kaul et al., 2002; Bhattacharya et al., 
2005; De Silva et al., 2009; Vibha & Prasad, 2012). The present study had comparable prevalence 
rates of hypertensive older adults in each ethnic group. Interestingly, two SA participants had 
untreated hypertension, which is common in this ethnic group. SAs are often unaware of the health 
risks associated with high blood pressure, and therefore, treatment for high blood pressure is 
inadequately pursued (Gupta et al., 2012, 2013; Anchala et al., 2014). Gupta and colleagues (2013) 
evaluated the prevalence of hypertension among middle-class SAs in India and found that half of 
the individuals with hypertension were aware of their condition, but more than half of these 
individuals were not receiving treatment. This implies that poorly treated hypertension is likely a 
distinct characteristic in the SA population, and thus, higher prevalence of hypertension could be 
a major contributing factor to increased susceptibility to cardio- and cerebrovascular diseases in 
this ethnic population. Hypertension is a manageable health condition that can be controlled by 
medical intervention, exercise and diet. Therefore, public awareness efforts as well as disease 
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management and prevention projects need to be considered to help fill the gaps in communication 
and understanding within SA communities in efforts to promote overall cardiovascular health. 
7.1.3 Ethnic Disparities in Vascular Structure  
SA older adults had trends for lower mean IMT, whereas the maximum IMT was 
significantly lower in SA compared to CA older adults (Table 6). This finding is consistent with 
a previous report by Anand and colleagues (2000) who also reported lower maximum IMT in SAs 
compared to CAs after adjusting for age and gender. Anand and colleagues (2000) found that the 
prevalence of cardiovascular diseases was greater in SAs even with reduced carotid IMT.  In the 
present study, the mean IMT value of the SA group was comparable to a recent multiethnic study 
that reported non-diabetic SAs had a mean IMT of 0.6 ± 0.1 mm (Kanaya et al., 2010). Carotid 
IMT is a well-established subclinical marker for atherosclerosis (pathological process of plaque 
buildup and hardening of the arterial lining). IMT is used to identify asymptomatic individuals at 
high risk of cardiovascular disease in the early stages of the disease process. Prospective and 
longitudinal studies have shown that IMT is associated with future risk of myocardial infarctions 
and stroke in general adult populations (Chambless et al., 1997, 2000; Iglesias del Sol et al., 2002), 
older adult populations (Bots et al., 1997; O’Leary et al., 1999), and multi-ethnic cohorts in the 
absence of major risk factors or clinical diseases (Polak et al., 2013). IMT is also independently 
associated with cardiovascular diseases in SAs (Jadhav & Kadam, 2001; Hansa et al., 2003; 
Meenakshisundaram et al., 2011). In the current study, IMT was used as an indicator of structural 
changes within the arterial system. It has been well-documented in the literature that SAs have an 
increased risk and prevalence of cardio- and cerebrovascular diseases (Anand et al., 2000; Lee et 
al., 2001; Gunarathne et al., 2009a; Palaniappan et al., 2010; Boparai et al., 2011; Tillin et al., 
2013; Hajra et al., 2013). Based on this information, it was anticipated that SA older adults would 
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have greater mean and maximum IMT compared to CA older adults, but this was not the case for 
maximum IMT values. Ethnic differences in IMT measurements observed in this study could 
potentially be explained by the differences in other risk factors that are associated with increased 
IMT, such as smoking status (Poredos et al., 1999; van den Berkmortel et al., 2000; Recio-
Rodriguez et al., 2013). The pathophysiological mechanisms that explain this association between 
current smoking status and increased IMT are related to changes in endothelial function (Tappia 
et al., 1995; Zeiher et al., 1995; Ichiki et al., 1996) and the elevation of inflammatory markers 
(Tracy et al., 1997) that promote atherosclerosis (Bazzano, 2003). The present investigation found 
that more CA participants were smokers, whereas the SA participants were neither current nor past 
smokers. Therefore, it is reasonable to speculate that the trend for greater mean IMT values and 
statistically greater maximum IMT observed in CA participants may have been related to their 
smoking behavior, but this argument cannot be confirmed from the present study. 
 
7.2 Ethnic Disparities in Cerebrovascular Hemodynamics 
7.2.1 Cerebral Blood Flow  
Contrary to the second hypothesis, lower aCBF was not observed in SAs; rather, SAs 
appeared to have trends for greater aCBF compared to CAs. Corresponding to this finding was that 
a trend for lower CVR and significantly higher PETCO2 values were observed in SAs compared to 
CAs. CO2 is a primary regulator of CBF, playing a particular role in mediating cerebrovascular 
tone. A multiple linear regression analysis revealed that 18% of the variance in aCBF was 
accounted for by the high PETCO2 levels in the SA group (APPENDIX D, Supplementary Table 
3). Although not measured in this study, decreased alveolar ventilation (CO2 elimination) may be 
a possible explanation for the observation of elevated PETCO2 in SAs (Munson et al., 1966). 
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Alveolar ventilation is defined as the volume of gas that enters the alveoli in the lungs for gas 
exchange and is expired out per minute (minute ventilation) corrected for physiologic dead space 
(Miller & Pardo, 2011). The alveolar ventilation equation (PACO2 = (V̇CO2 / V̇A • 0.863), where 
PACO2 is alveolar PCO2, V̇CO2 is CO2 output, V̇A is alveolar ventilation, and 0.863 is a constant 
that converts different standard units for V̇A (L/min, BTPS) and V̇CO2 (mL/min, STPD) to mmHg 
shows that for a constant V̇CO2, PACO2 would be elevated if V̇A is lower. In healthy human lungs, 
the alveolar PCO2 is approximately equivalent to arterial PCO2. In this regard, the elevated PETCO2 
observed in SAs relative to CAs might reflect a corresponding elevation in alveolar PCO2, and 
hence, and an elevation in arterial PCO2 (Jones et al., 1979). If indeed arterial PCO2 was elevated 
in the SAs, then it can be speculated that V̇A was lower in SAs. Lower ventilation allows CO2 to 
build up in the blood. Accordingly, it can be postulated that CAs and SAs have different arterial 
chemosensitivity to CO2. Central (located in the medulla) and peripheral (in the carotid arteries 
and aorta) arterial chemoreceptors are involved in the maintenance of arterial blood gases within 
homeostatic range. They stimulate the respiratory control center of the brain to change ventilation 
in response to changes in arterial PCO2, PO2, and pH (Sherwood, 2012). To test chemosensitivity 
to CO2, the ventilatory response to inhaled CO2 can be assessed. V̇A rises in response to increased 
arterial PCO2. Chemosensitivity to CO2 has not been investigated in the SA population; however, 
comparative studies between other ethnic populations have revealed significant differences in the 
ventilatory response to CO2 stimulus (Beral & Read, 1971; Willcox & Benatar, 1990). Beral & 
Read (1971) reported that New Guinea natives (an island north of Australia) had significantly 
lower ventilation when inhaling increased levels of CO2 compared to CAs. Another study found 
that compared to CAs, other ethnic groups have significantly lower ventilatory response to CO2 
(Willcox & Benatar, 1990). Furthermore, higher resting PETCO2 levels than CAs have also been 
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reported in other ethnic groups, such as African Americans (Anderson et al., 2001). Taken 
together, these studies support the notion that ethnic disparities in the tolerance or sensitivity to 
CO2 exist. Accordingly, the ethnic groups in the present study may have differences in CO2 
sensitivity, and thus, this could explain the trends observed for ethnic differences in resting CVR 
and aCBF. 
Furthermore, morphological and morphometric studies of the lungs have suggested that 
CAs have larger total lung capacity compared to SAs, likely attributed to greater inspiratory and 
expiratory muscle pressure and greater height in CAs (Whittaker et al., 2005). Chest dimension, 
height, and ethnicity have shown to explain 86% of the variation in total lung capacity among CA, 
SA and Chinese ethnic groups (Donnelly et al., 1991). Lung volumes tend to be larger in tall 
individuals than in short individuals. In the present study, there were obvious differences in body 
size between the SA and CA group; CA participants were taller and had significantly greater body 
surface area compared to SA group. Although the chest walls were not measured, it was postulated 
that CA participants in the study had physically larger chests; therefore, this could imply that CAs 
were able to distend their lungs more and have a higher ventilatory capacity to breathe more CO2 
out than SAs. The mechanisms underlying the differences in lung volumes are largely unknown. 
A recent study suggested that cultural, socioeconomic or environmental conditions do not explain 
the differences in lung volumes between CAs and SAs (Strippoli et al., 2013). Rather, the 
underlying basis for these ethnic differences could potentially be explained by genetic variation, 
differences in respiratory muscle strength, or elastic recoiling of the lung (Whittaker et al., 2005; 
Hirsch et al., 2013). However, data from the present study cannot confirm these speculations, and 
literature that examine these speculations are currently lacking. For this reason, more work in the 
SA population is required to confirm.  
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7.2.2 Cerebrovascular Function  
In contrast to the previous work by Bathula and colleagues (2011), the present study did 
not find significant differences in resting TCD-derived cerebrovascular hemodynamic variables 
between CAs and SAs; the ethnic groups had comparable resting supine values for MFV, RI and 
PI (Table 7). A trend was observed for greater resting supine SFV in SAs (p=0.063), which became 
significant in the seated position (p=0.030). Bathula and colleagues (2011) reported that SAs had 
greater cerebrovascular resistance (RI and PI) and MFV compared to CAs. Most importantly, they 
included participants with existing comorbidities in their study which might have confounded the 
results. For instance, there was a disproportionately greater number of diabetic patients in the SA 
group compared to the CA group. A study has shown that cerebral blood flow velocity and 
cerebrovascular resistance is significantly elevated in diabetic patients compared to healthy 
patients (Lee et al., 2000; Dikanovic et al., 2005). Accordingly, it can be speculated that the 
differences in cerebral hemodynamic measures between CAs and SAs in Bathula and colleagues 
(2011) study could be explained by the greater proportion of diabetic patients with abnormal 
cerebrovascular hemodynamics in the SA group. Conversely, the present study was designed to 
only include participants with no overt signs of chronic diseases to minimize the influence of such 
confounding factors. SA older adults in this study did not display significant differences to CA 
older adults in resting cerebral blood flow measurements obtained from the TCD.  
In addition, no differences in CO2 reactivity were detected between CAs and SAs (Table 
8). Although this finding did not confirm the third hypothesis of this study, an interesting finding 
was that absolute changes in PETCO2 and TCD-derived MFV were significantly larger in the SAs 
compared to CAs during hypercapnic conditions (Figure 2). The large increase in MFV was likely 
a consequence of higher and larger increase in PETCO2 observed in SAs. Even though the SAs and 
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CAs began the assessment at a similar PETCO2 level and inhaled the same concentration of CO2 
during hypercapnia, there was a significant difference in the change in PETCO2 during hypercapnia. 
Again, it appears that ethnic differences in ventilatory chemosensitivity might explain these 
results. It is possible that low ventilatory response to CO2 in SAs resulted in a significant increase 
in PETCO2 during hypercapnia, and therefore, this could contribute to the decrease in 
cerebrovascular resistance and subsequent increase in MFV. The present study was the first to 
examine ethnic differences in cerebrovascular reactivity between CAs and SAs. Considering the 
small sample size of this study and the success rate for successful TCD recordings in SAs was only 
72% (16/22), caution must be taken before drawing conclusions or making generalizations about 
the results. A technical consideration is that TCD is unable to measure MCA diameter. TCD is 
commonly used in the literature as a surrogate of estimating CBF under the assumption MCA 
diameter remains constant. Relative changes in MFV reflect proportional changes in CBF. 
However, the assumption of a constant MCA may be invalid under exposure to extreme hypoxic 
and hyercapnic conditions (Valdueza et al., 1999; Willie et al., 2012). Therefore, TCD may have 
underestimated measurements of CBF if changes in MCA diameter did occur. Importantly, SAs 
had greater PETCO2 change during hypercapnia compared to CAs, which may have caused the 
MCA to dilate in SAs. If this was the case, then for a given volume of blood flow, MCA dilation 
would decrease the resistance to flow and decrease MFV. As a consequence, MFV would 
underestimate true CBF. However, greater increase in MFV was observed in SAs in parallel with 
greater increase in PETCO2 during hypercapnia. Moreover, in the absence of supporting literature 
for ethnic differences in the effect of CO2 on arterial diameter, it is unknown whether the changes 
in MCA diameter may have impacted the results. The study findings clearly warrant further 
investigation using TCD to confirm these speculations. TCD is a valuable non-invasive technique 
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that enables the detection of flow abnormalities and may be promising tool to identify 
asymptomatic patients at high risk for development of cerebrovascular disease (Mok et al., 2012).  
 
7.3 Ethnic Disparities in the Effects of Arterial Stiffness on Cerebral Blood Flow  
Reduced carotid artery compliance, an indicator of regionally-specific arterial stiffness, in 
SA older adults was associated with greater cerebrovascular resistance (CVR) (Figure 6), and this 
was in turn associated with a greater reduction in aCBF compared to CAs (Figure 7). These 
findings supported the fourth hypothesis that elevated arterial stiffness in SAs would be associated 
with a greater reduction in aCBF relative to CAs. Increased CVR could reflect a compensatory 
mechanism by which the brain attempts to protect the microvessels from excessive pressure waves 
and pulsatile flow that were not being effectively managed by the central arteries. The transmission 
of poorly cushioned, high pulsatile flow is a hemodynamic stress that may damage arterial lining 
of cerebral vessels and induce chronic vascular structural alterations that increase myogenic 
vasoconstriction (Baumbach, 1996; Jacobsen et al., 2008; Mitchell et al., 2008; Takashi et al., 
2014).  As a consequence, greater CVR causes a reduction in CBF, potentially compromising 
cerebral perfusion and increasing the risk for ischemic events. Common carotid arterial stiffness 
is an independent risk factor for ischemic stroke (Tsivgoulis et al., 2005).  
This study did not detect a direct association between arterial stiffness (baPWV, PPcar, 
compliance or distensibility measures) and aCBF. Specifically, a relationship between baPWV and 
aCBF was not detected (Figure 5), and as a result, no ethnic differences in this relationship were 
detected between CAs and SAs. baPWV may not be a sensitive marker in detecting ethnic 
differences in arterial stiffness and its effect on aCBF. In addition, the lack of relationship between 
the two variables could be due to higher PETCO2 levels and a trend for higher aCBF observed in 
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SAs. Higher PETCO2 corresponds to higher arterial PCO2. It appears that SAs allowed their arterial 
PCO2 to be increased, which in turn, caused cerebrovascular dilation and increased aCBF. 
The link between the structural characteristics of central arteries and the hemodynamic 
properties of blood flow in the cerebral microcirculation was also explored. Although SAs 
appeared to have smaller IMT compared to CAs, there were still significant relationships with 
indicators cerebral hemodynamics, and that stronger relationships were observed in SAs. Mean 
carotid IMT was independently associated with both PI and RI in the MCA in SAs. The 
relationship between IMT and PI was also noted in CAs; however, increased IMT in SAs was 
associated with an even greater increase in PI and RI compared to CAs. PI and RI were cerebral 
hemodynamic indices derived from the TCD flow velocity waveforms that reflect intracranial 
resistance and compliance of small cerebral vessels downstream from the MCA. PI is the ratio of 
the amplitude of pulsation to the time average value of the blood flow velocity (SFV-DFV/MFV), 
and RI is the ratio of the amplitude of pulsation to the peak systolic blood flow velocity (SFV-
DFV/SFV). Independently, the SFV, DFV and MFV measurements used to calculate PI and RI 
were not significantly different between CAs and SAs (Table 7). As a result, no differences in PI 
and RI between the two ethnic groups were observed during baseline assessments. However, 
differences between the groups emerged when these indices were associated with IMT 
measurements. In spite of having less pronounced (maximum) IMT, SAs had greater PI and RI for 
a given IMT compared to CAs (Figure 10 & 11). The findings suggest that structural alterations 
of the carotid artery (arteriolosclerosis) were linked to more pulsatile blood flow patterns and 
resistance in the cerebral circulation, and that these relationships were more pronounced in SAs 
than in CAs. SAs may have had more advanced arteriosclerosis (hardening of arteries) as a 
consequence of increased arterial stiffness, and thus, it is speculated that arterial stiffness may 
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mediate the relationship between IMT and cerebral hemodynamics properties. Elevated pulsatile 
blood flow is associated with cerebrovascular damage (Webb et al., 2012a; Jolly et al., 2013). 
Thus, the finding from the present study provides valuable insight into the possible role of 
arteriosclerosis in the development of cerebral pathologies in the SA population. The changes in 
PI and RI may reflect changes in cerebral blood flow patterns that could be interpreted as a 
consequence of increased resistance in the cerebral microvessels due to prior damage, or may be 
caused by the direct transmission of high pulsatile pressure and flow from central arteries into the 
cerebral circulation (Mitchell et al., 2011; Aribisala et al., 2014). It is postulated that increased 
central arterial stiffness and reduced cushioning effect of pressure and flow by central arteries in 
SAs over time results in increased resistance in the cerebral microcirculation, and as a 
consequence, PI and RI are increased. However, no direct relationships between CVR (or CVRi) 
and PI or RI were found in this study, nor a significant association between central arterial stiffness 
and PI or RI. As a result, conclusive cause and effect relationships are difficult to determine. Thus, 
longitudinal studies are needed to elucidate the temporal relationship between arterial stiffness and 
hemodynamic changes in the cerebral microcirculation. 
 
7.4 Potential Ethnic Disparities in Plaque Burden  
Although this study was not designed to specifically look for plaque in the carotid arteries, 
plaque was seen in more SA participants than in CA participants during the imaging assessments. 
Atherosclerotic plaque buildup is a physical barrier in the arteries that can interrupt and interfere 
with the blood flow to the brain. The burden of plaque has been reported to be associated with 
increased risk of stroke in older adults free of CVD (Polak et al., 1998) and provides additive value 
in predicting the risk of future cardiovascular events in addition to IMT measurements (Nambi et 
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al., 2010, 2012; Polak et al., 2013). A recent study on SA patients with acute ischemic stroke 
reported that higher values of IMT, PI and RI were observed in these patients compared to healthy 
individuals, and that the degree of plaque was related to higher PI (Das et al., 2011). This implies 
that plaque buildup contributes to altered blood flow properties in the brain. Furthermore, seeing 
that IMT appears to be less in SAs compared to CAs, it was unclear whether the progression of 
plaque appears before the changes in IMT in SAs; in other words, plaque development could be 
an accelerated process in SAs, and thus, it could contribute to the increased risk of stroke reported 
in this population. A large prospective study has shown that the presence of carotid plaque relates 
to subsequent ischemic stroke (Chambless et al., 2000). Ischemic stroke is the most common type 
of stroke among SAs, followed by hemorrhagic stroke, as documented in both South Asian 
countries and in Western countries (Banerjee et al., 2001; Das et al., 2007; Dalal et al., 2008; 
Gunarathne et al., 2008a, 2009a; Kulshreshtha et al., 2012). It can be speculated that the burden 
of plaque in SAs is an important precursor contributing to the increased risk of cerebrovascular 
diseases. Some studies suggest that the progression of atherosclerosis in SA populations is 
associated with abnormal lipid profile (high LDL and low HDL cholesterol levels), diabetes (high 
glucose levels), higher systolic blood pressure, greater WHR, and high levels of thrombosis-
promoting factors like fibrinogen and  plasminogen activator inhibitor-1 (PAI-1) (Anand et al., 
2008; Chow et al., 2008). In the current study, higher levels of HDL, LDL, and HbA1c, and greater 
WHR were observed in SAs relative to CAs. Therefore, ethnic differences in these factors might 
have contributed to greater plaque formation and buildup detected in SAs. Again, the primary 
purpose of this study was not to investigate plaque. Plaque burden in SAs was an incidental finding, 
and therefore, additional research is recommended to confirm this observation. 
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7.5 Ethnic Disparities in Health Factors 
7.5.1 Blood Biomarkers  
SAs in this study were primarily non-diabetic, yet they had higher levels of HbA1c 
compared to non-diabetic CAs, consistent with other studies (Mostafa, 2012; Mebazaa et al., 
2013). On the other hand, fasting glucose levels were lower in SAs. Fasting glucose levels indicate 
the current level at the time the blood samples were taken, which can fluctuate throughout the day 
and with consumption of food (Lang et al., 1979; Jenkins, 1982, 1984; Read et al., 1986). All 
participants were required to fast overnight for at least 8 hours for morning blood draw. There is a 
possibility that some participants may not have had a meal the night before, and as a consequence, 
they may have had lower blood glucose levels in the morning (a condition known as fasting 
hypoglycemia) (Santiago, 1982; Yang et al., 1991).  Another possibility could be that participants 
may have experienced the “dawn phenomenon”, which is a condition that refers to the rise in 
glucose levels in the early hours of the morning (Schmidt et al., 1981; Bolli et al., 1984). This 
condition is related to the changes in the overnight release of glucose-regulating hormones which 
can affect the morning blood glucose levels (Van Cauter, 1990; Edge et al., 1990; Qin et al., 2003). 
As a result, fasting glucose levels might not be a stable marker that accurately measures glycemic 
control. On the other hand, HbA1c is considered a better indicator of glycemic control, reflecting 
the average blood glucose levels over the previous three months (Gonen et al., 1977; Nathan et 
al., 1984). Previous studies have found that fasting glucose and HbA1c levels are independently 
related to accelerated stiffening of arteries (van Popele et al., 2006; Rahman et al., 2008; Liang et 
al., 2012). In the present study, SAs displayed both elevated levels of HbA1c and arterial stiffness 
compared to CAs. However, correlation analyses employed in each ethnic group did not reveal 
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significant relationships between HbA1c and indicators of arterial stiffness. These findings should 
be interpreted with caution in light of the small sample size.  
Furthermore, additional markers of glycemic status (glycated albumin, insulin, and 
HOMA-IR) were chosen for examination in SAs, though data on these markers were unavailable 
in CAs because the decision had been made after the completion of data collection in CAs. As a 
consequence, the lack of a comparison group meant that comparison analyses between the two 
ethnic groups could not be performed. The rationale to include the aforementioned glycemic 
markers in this study was because glycated albumin has gained considerable clinical interest as a 
short-term measure of glycemic changes and has been proposed as a more accurate and useful 
measure of glycemic status than HbA1c (Silver et al., 1964; Schleicher et al., 1993; Ohkubo et al., 
1995; Juraschek et al., 2012). Also, several studies suggest that abnormal insulin sensitivity and 
glucose intolerance in individuals in the absence of diabetes are associated with increased arterial 
stiffness (Salomaa et al., 1995b; Sengstock et al., 2005; Seo et al., 2005; Sliem & Nasr, 2010; Paik 
et al., 2012; Meng et al., 2013; Shen et al., 2013). However, glycated albumin, insulin, and 
HOMA-IR did not show significant correlations with the indicators of arterial stiffness in SAs 
(Table 10). Despite these negative findings, comparable data on these markers and their potential 
role in arterial stiffness in the SA population are lacking. In light of the emerging evidence that 
suggests a role of impaired glycemic control and insulin resistance in increasing arterial stiffness, 
glycated albumin, insulin, and HOMA-IR may be promising markers for future investigations to 
evaluate glycemic control in the SAs and other populations with elevated arterial stiffness. 
7.5.2 Physical Activity 
SAs were physically inactive compared to CA older adults according to the self-reported 
physical activity. In addition, objectively measured physical activity data revealed that SAs took 
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fewer steps per day compared to CAs, implying that more time was spent in sedentary behavior. 
The recent Canadian Health Measures Survey reported that individuals aged 60 to 79 years 
averaged 7,900 steps a day for men and 7,000 steps a day for women (Colley et al., 2011). CA 
participants were well above the national average (CA males 9032 ± 2338 steps/day, CA females 
7158 ±  2851 steps/day), whereas SA participants were below the national average (SA males 
6,467 ± 2687 steps/day, SA females 4,593 ± 2548 steps/day). Physical inactivity among Canadian 
older adults is reported to be higher among visible minorities and immigrants (Azagba & Sharaf, 
2014). In Canada, the largest visible minority group is the SA population, and indeed, SAs are less 
active than the rest of the population (Tremblay et al., 2006; Liu et al., 2010). Physical inactivity 
is reported as a major health concern among SAs, which may account for this population’s greater 
prevalence of cardiometabolic risk (including diabetes, abdominal obesity, hypertension and 
hyperlipidemia) as compared to their CA counterparts (Fischbacher et al., 2004; Razak et al., 2005; 
Williams et al., 2010, 2011; Ranasinghe et al., 2013).  
7.5.3 Benefits of Physical Activity 
In spite of having lower levels of physical activity than CA older adults, SA older adults in 
this study displayed several health benefits to physical activity. For instance, greater physical 
activity was associated with lower HbA1c (Table 11). Elevated levels of HbA1c is an early indicator 
for the risk of developing future type-2 diabetes (Perry et al., 2001; Lee et al., 2002; Edelman et 
al., 2004; Hamilton & Jeyarajah, 2007; Inoue et al., 2007; Sato et al., 2009). Evidence suggests 
that a sedentary lifestyle (i.e. any waking behavior that has low levels of energy expended done in 
a sitting or reclining posture) (de Rezende et al., 2014) is strongly associated with greater risk of 
diabetes, cardiovascular diseases, and all-cause mortality (Katzmarzyk et al., 2009; Patel et al., 
2010; Hawkes et al., 2011). In addition, human bed-rest studies show that physical inactivity can 
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disrupt normal metabolic function and can consequently lead to insulin resistance, hyperlipidemia, 
and have deleterious effects on the vasculature (Bleeker et al., 2005; Hamburg et al., 2007; 
Alibegovic et al., 2009). Sedentary behavior has been shown to be associated with greater 
glycemic indices in SAs (Gill et al., 2011). More importantly, living a sedentary lifestyle in 
combination with a genetic susceptibility can substantially increase the risk of type-2 diabetes 
(Alibegovic et al., 2010). A genetic basis for the susceptibility of diabetes in SA population is 
evident with the variants of the transcription factor 7-like 2 gene (TCF7L2) (Chandak et al., 2007; 
Rees et al., 2008; Sanghera et al., 2008). The expression of this gene is involved in regulating 
glucose metabolism, and variants of this gene have been associated with impaired insulin secretion, 
glucose production and tolerance (Lyssenko & Lupi, 2007). Non-diabetic individuals who carry 
variants of this gene (such as SAs) display elevated levels of HbA1c and early signs of impaired 
glucose regulation (Gjesing et al., 2011; Gautier et al., 2011), and thus, these individuals are at a 
high genetic risk of developing type-2 diabetes. Fortunately, this study found that greater free-
living physical activity was associated with lower HbA1c in SAs, suggesting that physical activity 
could potentially attenuate the genetic predisposition to diabetes in SAs.  
Furthermore, physical activity measures in SA older adults were associated with lower 
waist circumference, WHR and lower levels of CRP. These associations have been confirmed 
previous studies that investigated physical activity interventions in SAs and found that SAs showed 
improvements in weight loss (Rush et al., 2007; Bhopal et al., 2014). Other studies have also seen 
physical activity in SAs to improve blood pressure and blood lipid profiles (Mathews et al., 2007). 
However, perceived barriers exist among SA older adults that hinder them from adhering to 
physical activity. For instance, pain is the most common reported complaint in SA older adults 
that makes them reluctant to exercise (Horne et al., 2013). Other factors including sweating, 
91 
 
increased heart rate, and breathlessness experienced with physical activity are negatively perceived 
as symptoms of illness rather than normal physiological responses to exercise (Hayes et al., 2002; 
Lawton et al., 2006). The fear of having these symptoms discourages the SAs to exercise. 
Therefore, it is imperative to investigate how to overcome these barriers and promote the benefits 
of undertaking regular physical activity.  
There is compelling evidence in the literature that physical activity is related to reduced 
arterial stiffness (Vaitkevicius et al., 1993; Gando et al., 2010; Miyazaki et al., 2011; O’Donovan 
et al., 2014). For that reason, a positive relationship between physical activity and arterial stiffness 
(baPWV) was an unexpected finding in the present study. This finding could be a statistical artifact 
as a result of intercorrelations with other variables; physical activity measures and baPWV were 
interrelated with WHR in CA older adults and with height in SA older adults.  Despite the negative 
findings, positive correlations between physical activity and CBF were observed in both ethnic 
groups, further supporting the benefits of physical activity. There is growing evidence that supports 
the notion that physical activity attenuates age-related decline in CBF (Rogers et al., 1990; Ainslie 
et al., 2008). Chronic reduction in CBF in older adults with increased risk of cardiovascular 
diseases is associated with higher risk of cardiovascular mortality and stroke (Markus, 2004; 
Sabayan et al., 2013). In this way, physical activity protects against the incidence of ischemic 
stroke. Some evidence suggests that the relationship between physical activity and CBF is 
mediated by an improvement in cerebral microvascular function (Barnes et al., 2013; Murrell et 
al., 2013; Bailey et al., 2013), although relationships between physical activity and 
cerebrovascular reactivity to CO2 were not observed in this study. Nonetheless, the beneficial 
effects of physical activity are multifaceted, and thus, emphasis should be placed on implementing 
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lifestyle interventions for high-risk ethnic minority populations that are culturally-targeted to 
reduce cardio- and cerebrovascular risk. 
 
7.6 Ethnic Disparities in Cognitive Performance 
The current study found that SA older adults were slower in performing reaction time 
cognitive tasks compared with CA older adults. These differences were not explained by 
differences in education. A growing body of literature suggests that greater central arterial stiffness 
is associated with accelerated brain aging (Waldstein et al., 2008; Sugawara et al., 2010; Mitchell 
et al., 2011; Zeki Al Hazzouri et al., 2013; Tsao et al., 2013; Singer, 2014). These studies observed 
negative relationships between cognitive test scores and arterial stiffness using various cognitive 
tasks (rather than the reaction time tasks) to assess different cognitive domains, such as executive 
functioning, verbal learning, nonverbal memory, and visual-spatial processing. These tasks have 
not be validated for all linguistic and cultural groups, and therefore, they cannot be used cross-
culturally to reliably represent an individual’s true abilities or characteristics fairly without 
introducing bias (Rait et al., 2000; Kristjansson et al., 2003). For this reason, it was appropriate to 
choose simple and nonlinguistic processing speed tasks (sRT and cRT) for the present study to 
reduce language and cultural bias. No relationships were observed in the current study between 
cognitive performance and arterial stiffness or brain blood flow. The reason for the lack of 
relationship might be because reaction time tasks were not sensitive to measure subtle changes in 
cognitive function associated with vascular aging in this small study sample. Although the findings 
differ from other studies, the present study presented a preliminary exploration of cognitive 
function and arterial aging among ethnic groups, and hence, future investigations are warranted. 
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8 Limitations 
 The study findings must be interpreted in light of the following limitations: i) the cross-
sectional design precludes causal inferences; ii) the small study sample limits the generalizability 
of results; iii) certain methodological limitations exist; and iv) data on nutrition or dietary status 
are lacking. 
i) The cross-sectional design of the study allowed comparisons to be made between ethnic groups 
and demonstrated several meaningful associations, but was not sufficient to establish causal or 
temporal relationships. 
ii) The study samples were small and selected at ease of participant availability, thereby limiting 
generalizability of the results. The CA participants were from a convenient sample of 
community-living older adults whose health status was maintained for university research, and 
the SA participants were exclusively Punjabi Sikh in origin, representing only one subgroup 
of the SA community. While the subgroups of the SA population are heterogeneous in regards 
to culture, lifestyle, religion, and socioeconomic status (Williams et al., 2010), nonetheless 
they all share an elevated risk of cardio- and cerebrovascular diseases.  
Another major issue with relatively small sample sizes is that significant differences between 
the groups may have been detected, but there is the risk of finding differences due to chance. 
Also, there is the possibility of missing real differences. As a result, it becomes difficult to 
interpret the implications of these results. Furthermore, the employment of extensive multiple 
comparison procedures and linear regressions would impose a statistical cost of loss of power. 
For this reason, a conservative approach was employed to maintain adequate statistical power 
to test the primary hypotheses of interest. The extent of linear regression analyses were 
restricted to preserve statistical power. While acknowledging these limitations, several 
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meaningful differences and relationships were identified that are consistent with the current 
literature. Most importantly, the study findings did confirm the primary hypotheses of this 
study in that i) arterial stiffness was elevated in SAs compared to age- and gender-matched 
CAs, and ii) greater arterial stiffness in SAs was associated with increased cerebrovascular 
resistance and corresponding decrease in aCBF. To verify the major outcomes of this study, 
future work should consider larger sample sizes which would be more representative of the 
general CA and SA populations (various SA subgroups included). 
iii) The first methodological limitation was that data were not collected by a single investigator, 
which may have introduced an interpretation bias for differences between the two groups. Ideal 
to have one investigator collect and analyze data for both groups, unfortunately not feasible in 
this study. Possible interpretation bias was dealt with by standardization of data collection and 
analysis techniques across the two groups to preserve comparability. Furthermore, a major 
challenge for interpreting is to determine to what extent the observed differences are due to 
ethnicity per se versus to differences in exposure to cardiovascular risk factors accumulated 
with aging, particularly in studies involving older adult populations. Certainly, ethnic 
disparities in health outcomes between CA and SA populations are evident, yet the underlying 
mechanisms are not fully elucidated. Findings from this study do provide unique insight into 
physiological differences between CA and SA ethnic groups that call for future work to 
investigate causal pathways and mechanisms to explain these differences and associations.  
 Second, different capnography devices were used to monitor ETCO2 in the CA and SA 
group, which might explain some of the differences observed in PETCO2 levels between the 
two groups. Due to technical issues, the capnography device used for the CA group (Pilot 9200, 
Colin Medical Instruments, San Antonio TX, USA) had to be substituted with a different 
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device for the SA group (Ohmeda 5200 spectroscopy CO2 Monitor, Madison WI, USA). There 
is a possibility that these devices had different pump speeds/sampling rates of the gas and 
different length and size of the sampling line that may have led to different ETCO2 readings. 
A slower sampling rate delays the response time of the initial rise of the signal, thereby slowing 
the time to reach the true peak (end-tidal) CO2 value for every breath. This, in turn, can result 
in underestimation of the PETCO2 values, and consequently, an underestimation of arterial 
PCO2. Furthermore, long or wide sampling lines can slow the response time, allowing the air 
in the tube or particulate matter to mix with the inhaled gas, which can cause erroneous 
readings of the CO2 values. Irrespective of these issues, both devices were consistent in the use 
of infrared absorption spectroscopy to continuously measure CO2. Both devices were also 
calibrated by the same concentration of gas (5% CO2) to ensure accurate CO2 measurements. 
Most importantly, this study found that the absolute change in PETCO2 when inhaling 5% CO2 
during hypercapnia was larger in SAs, which corresponded to a larger response in the change 
in MFV values. These results support the proposition that PETCO2 (and arterial PCO2) were 
indeed higher in SAs. Nevertheless, the differences in the capnography devices should be 
systematically examined in order to mitigate any issues that they may have influenced results. 
  Third, the posterior CBF through the vertebral arteries was not measured in this study. 
Vertebral arteries supply the brain a small portion (~20%) of the total CBF, whereas the 
majority (80%) of the total CBF is supplied by the (internal) carotid arteries (anterior CBF). 
Therefore, this study examined anterior CBF as a proxy measure of total CBF for the purpose 
to explore potential ethnic disparities in brain blood flow. In the future, measurements of both 
the posterior and anterior CBF will allow for the determination of total CBF. 
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  Fourth, the direct body surface measurements of the distance between the brachial and ankle 
arterial sites might have underestimated the true arterial path length, thereby introducing a 
potential source of error in baPWV measurements. Differences in body contour and height 
might have introduced measurement errors (Bossuyt et al., 2013; Sugawara et al., 2014). 
Formulas that account for body height have been proposed but not yet validated in populations 
with different anthropomorphic characteristics (Van Bortel et al., 2012; Levi-Marpillat et al., 
2013). Furthermore, there is no consensus in the literature regarding the optimal method to 
estimate pulse transit time. The present study estimated the pulse transit times by manually 
identifying the upstroke of each pressure wave, which is a time consuming process. Recently, 
Vardoulis and colleagues (2013) developed a computational algorithm (called diastolic 
patching) that determined the lowest point of the foot of the pressure waves based on the 
regional characteristic of that point. They proposed this method could accurately and precisely 
estimate the pulse transit time, but it has not yet been validated. Moreover, high resting HR 
can increase PWV measurements (Lantelme et al., 2002; Erik et al., 2004). Although the 
present study recorded pressure waveforms at the brachial and ankle arterial sites sequentially 
as opposed to simultaneously in the SA participants, resting HR did not significantly change 
between each measurement, indicating that HR variability in participants was minimal during 
the PWV assessment.  
  The fifth methodological limitation was that the Modelflow algorithm from the Finomater 
device may not have provided reliable estimates of model-derived cardiac output (Q) and total 
peripheral resistance (TPR) due to assumptions inherent in the algorithm.  The algorithm is 
based on a three-element Windkessel model that represents the three major properties of the 
arterial system: aortic impedance, arterial compliance, and systemic (peripheral) vascular 
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resistance. Aortic impedance and compliance of the model depend on the elastic properties of 
the aorta and are estimated from the nonlinear aortic pressure-area relationship, which was 
originally derived from a post mortem study (Langewouters et al., 1986). Langewouters and 
colleagues (1986) found that the aortic cross-sectional area is a function of pressure and a 
function of the individual’s age, gender, height and weight. However, this relationship does 
not capture aortic stiffening as a function of pressure. As arteries stiffen, they do not exhibit 
large changes in cross-sectional area in response to change in pressure. As a consequence, the 
Modelflow algorithm may not provide accurate estimates for individuals with stiff arteries. In 
addition, the algorithms used were not ethnic-specific, and thus, results should be interpreted 
with caution.  
  Sixth, the order of the cerebrovascular reactivity to CO2 in hypocapnic and hypercapnic 
conditions was not randomized. Hypocapnia was conducted prior to hypercapnia so that the 
CA and SA group protocol was consistent. To mitigate potential lingering effects of an 
individual’s response in the first condition influencing the response in the second condition, 
each participant was given 3 minutes between conditions, which was considered more than the 
ample time, to recover. Another generic methodological obstacle during cerebrovascular 
reactivity assessments is the use of PETCO2 as an estimate of arterial PCO2 (Robbins et al., 
1990). PETCO2 tends to overestimate arterial PCO2 in hypercapnic conditions, and 
consequently may lead to inaccurate estimates of cerebrovascular reactivity in hypercapnia 
(Peebles et al., 2007; Willie et al., 2012). The method to overcome this obstacle is to implement 
invasive arterial blood sampling of CO2; indirect estimation from expired gases is a method 
that encumbers all studies.  
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  Seventh, the major assumption of the TCD was that the MCA diameter did not change 
during experimental assessments; therefore, any change in cerebral blood flow velocity 
directly represented a change in cerebral blood flow (CBF). This assumption was based on 
previous studies that demonstrated minimal change in the MCA diameter in response to 
manipulations of ETCO2 (Bishop et al., 1986; Nuttall et al., 1996; Valdueza et al., 1997; 
Serrador et al., 2000; Peebles et al., 2007). Although widely adopted, this assumption has 
received legitimate criticism. Studies have found that the MCA diameter increases in 
hypercapnia (Valdueza et al., 1999; Coverdale et al., 2014). However, in the absence of 
magnetic resonance imaging (MRI) or positron emission tomography (PET) imaging 
techniques that directly measure CBF (Calamante et al., 1999; Zande et al., 2005; Vernooij et 
al., 2008), TCD was an alternative method to measure changes in CBF under the assumption 
that the manipulation of PETCO2 was within the range that did not result in significant changes 
in the MCA diameter. 
  Furthermore, the indices of cerebrovascular resistance (RI, PI, CVRi and CVR) were based 
on assumptions that must be considered when interpreting the findings. RI and PI were derived 
from the velocity spectral tracings to provide quantitative measures of flow patterns and 
resistance of the downstream cerebrovascular beds. PI has been used to describe the pulsatile 
characteristics of CBF and to reflect distal cerebrovascular resistance (Giller et al., 1990; Lim 
et al., 2009). However, PI does not solely represent the downstream resistance in the cerebral 
microcirculation; rather, PI is viewed as a complex function of several hemodynamic factors 
in addition to resistance, including cerebral perfusion pressure, compliance of cerebral arterial 
bed, and heart rate (de Riva, 2012) . Another drawback of RI and PI is that these indices do 
not account for the role of arterial pressure in CBF regulation. For this reason, CVRi (and 
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CVR), which does account for arterial pressure in the formula, was another index of 
cerebrovascular resistance used in this study. CVRi (and CVR) was estimated by the ratio of 
perfusion pressure, which was estimated by MAP corrected for the hydrostatic pressure 
difference at the level of the MCA, to the mean CBF velocity (and CBF). This relationship 
assumes that CBF ceases when the pressure is zero. However, it has been theoretically 
described that CBF stops when the cerebral vessels collapse below a critical threshold pressure 
(Burton, 1951; Dewey et al., 1974; Panerai et al., 1999; Aaslid et al., 2003), thereby affecting 
the interpretation of CVRi (and CVR). Alternative resistance indices that have been 
recommended by others are critical closing pressure and resistance area product. The critical 
closing pressure refers to the theoretical pressure at which CBF is zero. Direct measurements 
of the critical closing pressure are unethical in humans because it would require lowering 
arterial pressure to reach zero flow in the brain. Therefore, the critical closing pressure can be 
estimated by extrapolation from a linear model of the instantaneous relationship between 
cerebral blood flow velocity and blood pressure. The resistance area product represents the 
passive resistance between flow velocity and pressure. These measures have shown promising 
results in understanding the subtle changes in cerebrovascular tone (Robertson et al., 2014), 
and could be pursued in future studies to examine potential differences between ethnic 
populations. Clearly, several indices exist that aid in understanding the complex 
cerebrovascular system. Each of these indices provide unique information about 
hemodynamics in the cerebral vessels (Weyland et al., 2000; Kidwell et al., 2001; Gouveia et 
al., 2014; Varsos et al., 2014).  
  Lastly, the non-invasive, continuous monitoring of daily physical activity by the arm-band 
device (SWA) might have overestimated the resting metabolic rate (RMR) when compared to 
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the gold standard indirect calorimetry method (Heiermann et al., 2011), resulting in inaccurate 
estimates of the energy expended doing daily activities (AEE). Heiremann and colleagues 
(2011) have postulated that this could be due to age-related changes in skin conductance and 
temperature. Older adults have thinner, dryer skin, and sweating rates are lower (Silver et al., 
1964), which can affect the sensitivity of the SWA sensors, and therefore, impact the accuracy 
of the SWA algorithm estimations. For the purpose of this study, the SWA was an appropriate 
tool to assess physical activity and activity of daily living in older adults within a free-living 
setting with little disruption to their activity. The SWA data were also used to supplement the 
self-reported physical activity data, which are subject to recall bias and translation bias. 
iv) The present study did not examine the differences in dietary intake between the CAs and SAs. 
The justification of this decision was that there are no standardized dietary assessment tools 
that account for culture-specific foods. The dietary assessment tools currently used in research 
have been developed and validated in general populations (Beer-Borst & Amadò, 1995; 
Klipstein-Grobusch et al., 1998; Hu & Rimm, 1999; Jain et al., 2003). Some multi-ethnic 
cohort studies have evaluated the validity of diet records, but they have raised concerns about 
measurement errors in the design, analysis, and interpretation that likely result in 
underestimations of the actual food intake (Kristal & Feng, 1997; Kelemen et al., 2003; Mai 
et al., 2007). The food typical of SA diets is not commonly included in the food lists, and often 
times the diet is composed of complex dishes for which it is difficult to quantify individual 
amounts of recipe ingredients. There is a need for culture-specific diet assessment methods 
that are accurate and can be comparable between groups. As well, the rather small sample size 
of the present study would likely be subject to a high degree of variability in food intake 
between participants. As a result, meaningful interpretations of the results or reaching 
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definitive conclusions become difficult to achieve. Furthermore, dietary intake was not 
collected in the comparison group (CA group). Taken together, it was considered impractical 
to collect data on the diet of SA participants. In this regard, potential dietary effects cannot be 
discounted as studies have shown that certain diets can alter the degree of arterial stiffness 
(Avolio et al., 1986; Gates et al., 2004; Aatola et al., 2010; Chan et al., 2014).  
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9 Future Directions 
  In light of the small, cross-sectional design of this study, larger sample size studies are 
needed to confirm the findings. Furthermore, based on the study findings that SA older adults have 
stiffer central arteries than CA older adults, it’s possible that SAs have accelerated vascular aging. 
Increased arterial stiffness has been reported in young, healthy SAs in comparison to age- and 
gender-matched CAs (Din et al., 2006), implying that the vascular structure and function changes 
occur early in life for SAs. The well-described phenomenon of arterial stiffness and decline in 
CBF with aging may be enhanced in SAs at an early age. Future work should consider comparing 
young and old SAs and also follow them, along with CAs, prospectively to evaluate racial 
differences in the longitudinal change in arterial stiffness and its role in the differential 
development of cardio- and cerebrovascular diseases between these ethnic groups. These studies 
would determine whether arterial stiffness is accelerated with advancing age in SAs compared to 
CAs at younger age, or if it is accelerated in SAs later in life. The indicators of increased arterial 
stiffness, including faster PWV, decreased compliance, and elevated central pulse pressure, that 
were observed in SAs in this study all have clinical relevance in predicting cardio- and 
cerebrovascular disease events and mortality in the general population (Shokawa et al., 2005; 
Sutton-Tyrrell et al., 2005; Mattace-Raso et al., 2006; Tsivgoulis et al., 2006; Mitchell et al., 
2010). In this regard, assessment of the prognostic value of arterial stiffness in high-risk 
populations like the SAs warrant further investigation. In addition, longitudinal studies are 
required to delineate the temporal relationship between central arterial stiffness and hemodynamic 
changes in the cerebral circulation that may associated with increased risk of cerebrovascular 
damage (Henskens et al., 2008; Mitchell et al., 2011; Poels et al., 2012a).  
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Indeed, increased arterial stiffness in SAs may be a complex integration of the effects of 
genetics (Lacolley et al., 2009) and cumulative damage of cardiovascular risk factors on the 
vasculature over time, but this progression of arterial stiffness can be slowed down with lifestyle 
interventions, such as regular physical activity (Tanaka et al., 2000), medications (Ferrier et al., 
2002; Ichihara et al., 2005; Kanaki et al., 2013; Oh et al., 2014), and with modifying other 
cardiovascular risk factors (e.g., hypertension, diabetes, and hyperlipidemia). It is unknown the 
extent to which these factors attenuate arterial stiffening in SA populations, and therefore, future 
work should consider examining the intensity level of physical activity and dose of medication 
that may be needed to reduce arterial stiffness in high-risk populations, such as SAs, who have 
elevated arterial stiffness compared to the rest of the population. Also, these studies must consider 
the cultural barriers towards interventions that may pose particular challenge when studying the 
SA ethnic population. Furthermore, it may be beneficial to target the SA population at a young age 
to help to reduce the risk for early development of future cardiovascular events (van de Laar et al., 
2010).  
Atherosclerosis may also contribute directly to the acceleration of vascular aging in SA 
populations. A follow up investigation is required to determine plaque prevalence in SAs and to 
examine whether plaque and IMT progression in SAs is similar to or greater than that of other 
ethnic groups. It would be valuable to evaluate the factors that contribute to the progression of 
subclinical atherosclerosis in this population to understand the underlying mechanisms 
contributing to the ethnic disparities in disease risk and prevalence. Genetic factors are currently 
being studied in SAs to understand the genetic link to cardio- and cerebrovascular diseases. Some 
studies have found strong genetic predisposition to diabetes (Kooner et al., 2011) and coronary 
artery disease (Kooner et al., 2011), but it is unclear whether there is a genetic contribution (i.e. 
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change in gene expression or gene polymorphism) to vascular remodeling and increased age-
related arterial stiffening in SAs (Medley et al., 2003, 2004; Mitchell et al., 2005). Understanding 
the genetic basis is essential to identify the molecular pathways that might be involved in ethnic 
differences in susceptibility and pathology of diseases.   
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10 Conclusion 
 The major findings of the present investigation were that SA older adults had larger pulse 
pressures, lower diastolic pressure, and reduced central arterial compliance – all indicators of 
arterial stiffening – compared to age- and gender-matched white Caucasian older adults. This study 
supports a link between increased central arterial stiffness, specifically reduced arterial 
compliance, and increased cerebrovascular resistance which in turn is associated with reduction in 
CBF in SAs. Furthermore, the extent of atherosclerosis as measured by IMT appeared to be less 
pronounced in SAs compared to CAs, but greater IMT in SAs was associated with even greater 
increase in pulsatile and resistant blood flow in the cerebral vessels. Taken together, these findings 
suggest that cerebrovascular hemodynamic changes may be influenced by the structural and 
functional alterations of central arteries, and that this appears to be more pronounced in SAs. It 
seems reasonable to speculate that SAs are vulnerable to the harmful effects of arterial stiffening, 
particularly in old age. Increased arterial stiffness may underlie the disproportionate burden of 
cardio- and cerebrovascular diseases, such as myocardial infarction and stroke, in SAs. A greater 
understanding of the determinants of increased arterial stiffness in this high risk ethnic population 
is required to inform intervention efforts to slow the process of arterial stiffness with aging and its 
effects on organs, such as the brain. 
 The study findings provide unique and meaningful insight into physiological differences 
between CAs and SAs before the onset of overt cardio- and cerebrovascular diseases. Given that 
SAs have greater susceptibility and prevalence of these diseases, follow up investigations are 
required to determine whether differences in arterial stiffness and cerebrovascular hemodynamic 
properties are early indicators of cardio- and cerebrovascular disease processes, thereby being 
useful predictors of future disease development. The key to managing potentially preventable and 
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treatable diseases in high risk populations lies in understanding the underlying mechanisms that 
contribute to the ethnic disparities in health outcomes. This study reveals highly relevant ethnic 
disparities that could aid in understanding differences in disease risk. 
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APPENDIX A – INCLUSION AND EXCLUSION CRITERIA 
Inclusion Criteria 
 Male and female participants of South Asian origin (immigrant or Canadian-born) greater 
or equal to 65 years of age and older 
Exclusion Criteria  
 History of stroke (cerebrovascular disease); 
 Carotid endarterectomy or stent; 
 Atrial fibrillation or heart failure; 
 Heart attack/angina; 
 Open heart surgery; 
 Chronic inflammatory diseases, such as arthritis; 
 Neurological disorders, such as Parkinson’s disease; 
 Diagnosed with dementia or cognitive disorders; 
 Signs of cognitive deficits demonstrated by the inability to understand and provide 
informed written consent for participation in the study; 
 Significant hearing and vision problems identified by self-report; 
 Metastatic or current cancer; 
 Chronic kidney disease; 
 Unstable health (overnight hospitalization with the past 12 months); 
 Previous allergic, sensitivities or other reactions to gels or adhesives that may be used 
for the heart rate electrode
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APPENDIX B – AGING HEALTH QUESTIONNAIRE 
Health History 
1.  Your Background 
1. What is your birthdate? 
  ________________ (MM/DD/YYYY)       (____ years old) 
 
2. People living in Canada come from many different cultural and racial backgrounds.  
   Are you? (Check (√) all that apply) 
  □ Aboriginal       □ 1st Nation □ Inuit                                        □ Métis 
□ White        □ Black  □ Southeast Asian (i.e., Vietnamese) 
□ Filipino        □ Chinese        □ South Asian (i.e., East/South Indian, Pakistani) 
□ Latin American                       □ Other: _____________________________ 
 
3. What is your primary language?        _____________________________ 
4. What language did you first learn to speak as a child? ___________________ 
 
5. In what languages can you conduct a conversation?    ___________________  
 
6. What is your birthplace?             
     City/Town___________________ Province____     
           If born outside Canada,       Country __________ Years in Canada: _____ 
 
7. What is your mother’s birthplace?   
     City/Town ________________ Province_____ 
           If born outside Canada,         Country_________________  
 
8. What is your father’s birthplace?     
     City/Town______________________ Province_____      
     If born outside Canada,         Country_________________  
 
2.  Your Marital Status 
  □ never married 
  □ married or living with a partner 
  □ widowed, not currently married 
  □ divorced, not currently married 
  □ separated 
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3.  Your Education 
 
1. What are your total years of formal education (includes grades 1 and higher):  
     ______years  
 
 
2. What diplomas, certificates or degrees have you obtained? 
 (Check (√) all that apply) 
 
   □ None                                          □ High School             
  □ Trade certificate/diploma  □ Community college diploma  
□ University undergraduate degree □ University graduate degree 
 
 
4.  Your Occupation 
 
1. What kind of work did you do for most of your life? 
________________________________________________________ 
 
2.  If you did not work for pay, what did your spouse do for most of their life? 
 _________________________________________________________ 
 
3.  Are you working for pay now? 
  If yes, please check (√): □ casual 
      □ part time 
      □ full time 
  If no, year last worked ___________  or □ never worked 
 
 
 
 
 
 
 
 
 
 
141 
 
5.  Your Related Chronic Health Checklist   (Check (√) all that apply to you) 
 
 
 
□ 
 
□ 
 
□ 
 
Cardiovascular (heart) risk factors: 
 
Hypertension (high blood pressure)  (Go to 
Question 1a)        
Hyperlipidemia (high cholesterol) 
(Go to Question 1b)        
Diabetes mellitus 
(Go to Question 1c) 
 
Insulin Dependent 
 
 
  □ 
  □  
   
  □ 
  □ 
  □ 
Gastrointestinal (stomach/intestine): 
 
Irritable bowel syndrome 
Heart burn/esophageal reflux disease (GERD) 
Peptic ulcer disease 
Gall bladder 
Other: _________________ 
 
 
 
□ 
□ 
□ 
□ 
□ 
□ 
 
Pulmonary (lung): 
 
 Chronic bronchitis 
 Emphysema 
 Asthma 
 Other lung disease:_______________ 
 Sleep apnea 
 Other sleep disorders:_____________ 
 
 
 
  □ 
  □ 
 
 
 
  □ 
  □  
   
 Musculoskeletal(muscles/bones): 
 
Osteoporosis 
Low intensity trauma fracture 
                □ Hip 
                □ Vertebral 
                □ Wrist 
Osteoarthritis 
Other: __________________ 
 
 
 
  □ 
  □ 
  □ 
  □ 
  □ 
  □ 
 
Neurological (Brain)/Psychiatric (Mood): 
 
 Seizure disorder 
 Migraine 
 Depression 
 Schizophrenia 
 Manic depression/bipolar 
 Anxiety disorder (generalized, panic, phobia, 
etc.)          
                                                                                                                                                  
 
 
  □ 
  □ 
Anemia (blood disorders): 
 
 Sickle cell anemia 
 Hypercoaguable (blood clotting) states or 
related conditions: 
             □ DVT 
                    - deep vein thrombosis                        
             □ Pulmonary emboli 
                    - blood clot in the lung 
  □ Cancer: 
   Specify type and location:    
    _______________________ 
  □ Color blind 
1. How long have you had:         a) Hypertension?       ____ years. 
b) Hyperlipidemia?    ____ years. 
c) Diabetes?               ____ years. 
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6.  Your Surgeries    
                                                            
Date (month and year) Surgery (type of surgery, area of body) 
  
  
  
  
 
 
7.  Your Medications (including supplements) taken within the last week. 
 
Medication Name 
 
(Prescription:Y/N)  
Strength 
(mg) 
Route:  
(e.g. by mouth, 
on skin, 
inhaled) 
Frequency: 
(e.g., 1x/day,  
4x/day) 
Duration: 
(How long have 
you been taking 
the medication, 
in years?) 
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1. Do you take any herbal medications? 
 
Yes   No 
 
2. What is the purpose of taking the herbal medicine? 
 
____________________________________________________________________
____________________________________________________________________
_______________________________________________ 
 
8.  Medication Adherence  
Thinking of the medications PRESCRIBED to you by your doctor(s), please circle the most 
appropriate response for each question. 
  
1.  Do you ever forget to take your medications? 
 
 Never   Rarely        Sometimes       Often        Always 
 
2.  Are you careless at times about taking your medications?  
 
 Never   Rarely        Sometimes       Often        Always 
 
3.  When you feel better, do you sometimes stop taking your medications? 
 
 Never   Rarely        Sometimes       Often        Always 
 
4.  Sometimes if you feel worse when you take your medications, do you stop taking them?  
 
 Never   Rarely        Sometimes       Often        Always 
 
5.  Many people have trouble taking their medications exactly as prescribed by their doctor. 
Thinking back to the last time you didn’t take your medication(s) as prescribed, can you 
describe why?   
____________________________________________________________________ 
_________________________________________________________________ 
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9.  Your Family Health History   
 
Please make a checkmark (√) for family members (blood relations only) who have any of 
these conditions or has passed away from them.   
 
 
                  
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
10. Alcohol Use 
    The next 6 questions are about drinking alcoholic beverages.  
     Included are liquor (such as whiskey or gin), beer, wine, wine coolers and any other  
     type of alcoholic beverage. 
 
 
 
 
1. In any one year, have you had at least 12 drinks of any type of alcoholic beverage?  
  
               □ Yes (go to Question 3) 
    □ No (Continue to Question 2) 
 
 
CONDITION 
 M
o
th
er
 
F
at
h
er
 
B
ro
th
er
s 
S
is
te
rs
 
S
o
n
s 
D
au
g
h
te
rs
 
 
Heart Attack   
      
 
Angina 
      
 
High Blood Pressure 
      
 
Peripheral Vascular Disease 
      
 
Stroke  
      
 
Dementia 
      
       1 drink  = 12 oz. of beer 
 = 5 oz. of wine 
   = 1 ½ oz. of liquor   
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2. In your entire life, have you had at least 12 drinks of any type of alcoholic beverage?  
 
□ Yes 
□ No (end of alcohol questions             Go to 12. Tobacco Use section.)  
 
3. In the past 12 months, how often did you drink any type of alcoholic beverage?  
(That is, how many days per week, per month or per year did you drink?) 
 
Number of days: ________             per (check one)   □ week 
     □ month 
  □ year         
 
 
4. In the past 12 months, on those days that you drank alcoholic beverages, on average, 
how many drinks did you have? 
 
 Number of drinks: __________  
 
5. In the past 12 months, on how many days per week, per month or per year did you 
have 5 or more drinks of any alcoholic beverage in a single day? 
 
Number of days: ________             per (check one)   □ week 
     □ month 
  □ year         
 
6. Was there ever a time or times in your life when you drank 5 or more drinks of 
any kind of alcoholic beverage almost every day? 
  □ Yes 
□ No  
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11. Tobacco Use 
 
 
    Section A 
1. Have you smoked at least 100 cigarettes in your entire life?   
  □ Yes  
  □ No (go to Section B – Question 1)  
 
2. How old were you when you first started to smoke cigarettes fairly regularly? 
   _____ age (in years)   
                  □ never smoked cigarettes fairly regularly                   
 
3. Do you now smoke cigarettes? (check one) 
  □ every day (go to Question 6) 
  □ some days (go to Question 6)  
  □ not at all (Continue to Question 4)  
4. a) How old were you when you last smoked cigarettes fairly regularly? 
_____ age (in years)   
 
b) If you quit smoking regularly in this past year, how many weeks has it been?  
______ weeks 
 
5. At that time, how many cigarettes did you usually smoke per day? 
  
 
Number of cigarettes/day___________ 
or 
Section A is about cigarette smoking. 
Section B is about cigar, pipe and other tobacco use.  
 
1 pack = 20 cigarettes 
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Number of packs/day_____________ 
(If you no longer smoke, skip Questions 6 & 7          go to Section B) 
 Current Smoking status: 
6. During the past 30 days, on how many days did you smoke cigarettes?  
Number of days_____________ 
 
7. During the past 30 days, on the days that you smoked, how many cigarettes did 
you smoke per day?  
   
 
 
Number of cigarettes/day_____________ 
or 
Number of packs/day______________ 
Section B 
   
   
1.  Have you ever smoked a pipe, smoked a cigar or used smokeless tobacco? 
  Pipe     □ No     □ Yes 
 Cigar     □ No     □ Yes     
Smokeless tobacco  □ No     □ Yes       
(If ‘No’ to all        go to 12. Physical Activity section). 
 
2. How old were you when you first started to smoke a pipe/cigar/smokeless tobacco    
 regularly? 
   _____ Age (in years)   
                      □ never smoked regularly    
 
1 pack = 20 cigarettes 
Cigars include cheroots and cigarillos. 
Smokeless tobacco includes chewing tobacco or snuff. 
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3.  Do you currently smoke a pipe, smoke a cigar or use smokeless tobacco?  
 Pipe     □ No        □ Yes 
 Cigar     □ No         go to Question 4   □ Yes         go to Question 5 
Smokeless tobacco  □ No        □ Yes 
 
4. a) How old were you when you last smoked a pipe/cigar/smokeless tobacco  
    regularly? 
   _____age (in years)   
a) If you quit smoking regularly in this past year, how many weeks has it been?  
 
     ______ weeks. 
 
 Go to 12. Physical Activity section. 
 
5.  On average, how many times a week do you smoke a pipe, smoke a cigar or use 
smokeless tobacco? 
    Pipe    ___ (times per week)  
    Cigar    ___ (times per week)  
    Smokeless tobacco  ___ (times per week) 
 
 6.  On average: 
      How many pipes full of tobacco do you smoke each week? _____ 
      How many cigars do you smoke each week? _____ 
      How much smokeless tobacco do you use each week? _____ 
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12. PHYSICAL ACTIVITY  
Physical activity is any form of body movement that requires effort, but does not include 
routine activities of daily living such as self-care and cooking. Physical activity can be 
required for work or transportation, or for pleasure. 
The intensity of physical activity refers to the amount of effort you put into the activity. It 
can be judged on a 10-point scale, where ‘0’ is sitting and ‘10’ is all out effort, or it can be 
described in terms of how much you are sweating and breathing. To help us group activities 
together, we split intensity into 3 categories: LIGHT, MODERATE and HARD. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LIGHT: 2-4 on a scale from 0-10.  
No sweating, but faster breathing. 
(e.g., walking) 
 
MODERATE: 5-6 on a scale from 0-10.  
Some sweating and deeper breathing, 
but still able to talk comfortably. 
(e.g., brisk walking or biking) 
 
HARD: 7-8 on a scale from 0-10.  
Heavy sweating and heavy breathing 
with difficulty talking. 
(e.g., running or swimming) 
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1. This question asks you to list specific activities that you have regularly performed 
during the past 4 months. List any regular activity from gardening to running. 
Circle the appropriate Frequency and Duration for each Activity you list.  
Intensity might vary within the activity. Please indicate the percentage of time 
you spend at each Intensity for all the Activities you list. An example listing has 
been completed in the first row. 
 
 
 
Activity Description 
 
Frequency 
(# of sessions 
per week) 
Duration 
(minutes per session) 
Intensity 
(described above) 
e.g. Cycling 1-2    3-4    5+ 
up to 20   20-30   30-60   
60+ 
 
Light   Moderate   Hard 
 50%          50%         0% 
 
 
1-2    3-4    5+ 
up to 20   20-30   30-60   
60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
 
 
1-2    3-4    5+ 
up to 20   20-30   30-60   
60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
 
 
1-2    3-4    5+ 
up to 20   20-30   30-60   
60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
 
 
1-2    3-4    5+ 
up to 20   20-30   30-60   
60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
 
 
1-2    3-4    5+ 
up to 20   20-30   30-60   
60+ 
Light   Moderate   Hard 
  ___%     ___%       ___% 
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2. This question asks you about the amount of regular physical activity you perform. 
Only consider activities you perform for at least 20 continuous minutes at a 
time.  
Please check one box in each intensity category that describes the frequency of 
your average physical activity habits during the past year. 
 
        a) I have engaged in LIGHT physical activity:  
   □ No days per week 
 □ 1 to 4 days per week 
 □ At least 5 days per week 
 
       b) I have engaged in MODERATE physical activity: 
   □ No days per week 
 □ 1 or 2 days per week 
 □ 3 or 4 days per week 
 □ At least 5 days per week 
 
       c) I have engaged in HARD physical activity:  
   □ No days per week 
 □ 1 or 2 days per week 
 □ 3 days per week 
 □ At least 4 days per week 
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3. Next, we would like to know about your average Physical Activity level at specific 
periods in your entire adult life.  For each time period, please indicate the how 
often you participated in LIGHT, MODERATE and HARD physical activity. 
Your age, in 
years 
Physical Activity 
Light 
(Check one) 
Moderate 
(Check one) 
Hard 
(Check one) 
 
64 years to 
present (minus 
the year you 
already 
answered in 
Question 2) 
 
□ No days per week 
□ 1 to 4 days per week 
□ At least 5 days per 
week 
 
 
□ No days per week 
□ 1 or 2 days per week 
□ 3 or 4 days per week 
□ At least 5 days per week 
 
 
□ No days per week 
□ 1 or 2 days per week 
□ 3 days per week 
□ At least 4 days per week 
51-64 years 
 
□ No days per week 
□ 1 to 4 days per week 
□ At least 5 days per 
week 
 
□ No days per week 
□ 1 or 2 days per week 
□ 3 or 4 days per week 
□ At least 5 days per week 
 
□ No days per week 
□ 1 or 2 days per week 
□ 3 days per week 
□ At least 4 days per week 
31 – 50 years 
 
□ No days per week 
□ 1 to 4 days per week 
□ At least 5 days per 
week 
 
□ No days per week 
□ 1 or 2 days per week 
□ 3 or 4 days per week 
□ At least 5 days per week 
 
□ No days per week 
□ 1 or 2 days per week 
□ 3 days per week 
□ At least 4 days per week 
18-30 years 
 
□ No days per week 
□ 1 to 4 days per week 
□ At least 5 days per 
week 
 
□ No days per week 
□ 1 or 2 days per week 
□ 3 or 4 days per week 
□ At least 5 days per week 
 
□ No days per week 
□ 1 or 2 days per week 
□ 3 days per week 
□ At least 4 days per week 
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4.  These next questions are about strength training (weight lifting). 
 a) In the last year, I have been lifting weights, on average (check one): 
   □ Twice or more a week      □ Once a week       □ Less than once a week      
 □ Never 
 
 b)  In my entire adult life, I have been lifting weights, on average (check one): 
       □ Twice or more a week      □ Once a week       □ Less than once a week       
□ Never 
 
Additional Comments:  
_____________________________________________________________ 
_____________________________________________________________ 
 
Fitness Centers/Clubs 
 
  1. Do you belong to a fitness group or club (i.e., in your building or in and around 
       your neighborhood)? 
 
__Yes  
__No  
 
End of Questionnaire. 
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APPENDIX C – SELF-REPORTED PHYSICAL ACTIVITY SCORING  
                       GUIDELINE 
 
a) I have engaged in LIGHT physical activity:  
 □ No days per week 
 □ 1 to 4 days per week 
 □ At least 5 days per week 
 
b) I have engaged in MODERATE physical activity: 
 □ No days per week 
 □ 1 or 2 days per week 
 □ 3 or 4 days per week 
 □ At least 5 days per week 
 
  c) I have engaged in HARD physical activity:  
 □ No days per week 
 □ 1 or 2 days per week 
 □ 3 days per week 
 □ At least 4 days per week 
 
 
 
 
 
 
 
 
0 
1 
2 
 
0 
2 
3 
5 
 
 
0 
3 
7 
9 
 
Add the scores for a, b and c: 
Inactive:                 0-2 points 
Active Lifestyle:     3-6 points 
Highly Active:         >7 points 
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APPENDIX D – SUPPLEMENTARY ANALYSES 
 
Supplementary Table 1. Physical Activity Measurements in Participants with Two-Day and 
                                          Three-Day Data Collection 
 CA SA 
 
2 days 
(n=2) 
3 days 
(n=20) 
p-
value† 
2 days 
(n=7) 
3 days 
(n=13) 
p-
value† 
TEE, kcal/day 
Steps, count/day 
1974 + 278 
8530 + 4622 
2359 + 396 
8052 + 2651 
0.198 
0.819 
1946 + 456 
5601 + 3065 
2193 + 408 
5636 + 2665 
0.231 
0.979 
Data were presented as mean + SD. TEE, total energy expenditure. 
† Statistical significance using two-tailed unpaired t-test. p ≤ 0.05 was considered statistically 
significant. 
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Supplementary Table 2. Physical Activity Data Collection during the Weekdays Only and  
                                          Including Weekends  
 CA SA 
 
Weekdays 
only 
(n=10) 
Includes 
Weekends 
(n=12) 
p-value† 
Weekdays 
only 
(n=13) 
Includes 
Weekends 
(n=7) 
p-value† 
PAEE, kcal/day § 
 
Duration of PA, 
hour/day § 
17 + 7 
 
1.1 + 0.4 
18 + 7 
 
1.1 +  0.4 
0.798 
 
0.809 
15 + 10 
 
1.0 + 0.6 
16 + 5 
 
1.0 + 0.3 
0.902 
 
0.880 
Data were presented as mean + SD. TEE, total energy expenditure; PAEE, physical activity-related 
energy expenditure; PA, physical activity. 
§ Duration of daily PA and PAEE were square root transformed. 
† Statistical significance using two-tailed unpaired t-test. p ≤ 0.05 was considered statistically 
significant. 
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Supplementary Table 3. Multiple Linear Regression Model of Ethnicity and End-Tidal  
                                            Carbon Dioxide with Anterior Cerebral Blood Flow  
Dependent 
Variable 
Ethnicity Models β p-value† 
Model 
Adjusted R2 
aCBF 
CA (n=19) PETCO2 -0.004 0.62 0.00 
SA (n=21) PETCO2 0.024 0.02 0.21 
Both (n=41) 
PETCO2 0.012 0.03 0.09 
PETCO2 
Ethnicity 
0.009 
0.046 
0.16 
0.35 
0.09 
PETCO2 
Ethnicity 
PETCO2 * Ethnicity 
0.004 
-1.047 
-0.028 
0.64 
0.04 
0.03 
0.18 
aCBF, anterior cerebral blood flow; CA, white Caucasians; SA, South Asians; PETCO2, end-tidal 
carbon dioxide. 
Data were presented as parameter estimates (β) for PETCO2, ethnicity and the interaction term 
between ethnicity and PETCO2, significance of parameter estimate (p-value), and explained 
variance R2 of the model. 
† Statistical significance using two-tailed unpaired t-test. p ≤ 0.05 was considered statistically 
significant. 
